
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">



<head prefix="og: http://ogp.me/ns#">
  <title>Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells</title>




<link rel="stylesheet" href="/resource/css/screen.css?e8097f76cb8c3b543f00c9cde49751d6"/>
  <!-- allows for  extra head tags -->


<!-- hello -->
<link rel="stylesheet" type="text/css"
      href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,600">

<link media="print" rel="stylesheet" type="text/css"  href="/resource/css/print.css"/>
    <script type="text/javascript">
        var siteUrlPrefix = "/plosone/";
    </script>
  <script src="/resource/js/vendor/modernizr-v2.7.1.js" type="text/javascript"></script>
  <script src="/resource/js/vendor/detectizr.min.js" type="text/javascript"></script>

  <link rel="shortcut icon" href="/resource/img/favicon.ico" type="image/x-icon"/>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>






  <link rel="canonical" href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0087003" />
  <meta name="description" content="High level MYC expression is associated with almost all human cancers. JQ1, a chemical compound that inhibits MYC expression is therapeutically effective in preclinical animal models in midline carcinoma, and Burkitt&rsquo;s lymphoma (BL). Here we show that JQ1 does not inhibit MYC expression to a similar extent in all tumor cells. The BL cells showed a &sim;90% decrease in MYC transcription upon treatment with JQ1, however, no corresponding reduction was seen in several non-BL cells. Molecularly, these differences appear due to requirements of Brd4, the most active version of the Positive Transcription Elongation Factor B (P-TEFb) within the Super Elongation Complex (SEC), and transcription factors such as Gdown1, and MED26 and also other unknown cell specific factors. Our study demonstrates that the regulation of high levels of MYC expression in different cancer cells is driven by unique regulatory mechanisms and that such exclusive regulatory signatures in each cancer cells could be employed for targeted therapeutics." />

  <meta name="citation_abstract" content="High level MYC expression is associated with almost all human cancers. JQ1, a chemical compound that inhibits MYC expression is therapeutically effective in preclinical animal models in midline carcinoma, and Burkitt&rsquo;s lymphoma (BL). Here we show that JQ1 does not inhibit MYC expression to a similar extent in all tumor cells. The BL cells showed a &sim;90% decrease in MYC transcription upon treatment with JQ1, however, no corresponding reduction was seen in several non-BL cells. Molecularly, these differences appear due to requirements of Brd4, the most active version of the Positive Transcription Elongation Factor B (P-TEFb) within the Super Elongation Complex (SEC), and transcription factors such as Gdown1, and MED26 and also other unknown cell specific factors. Our study demonstrates that the regulation of high levels of MYC expression in different cancer cells is driven by unique regulatory mechanisms and that such exclusive regulatory signatures in each cancer cells could be employed for targeted therapeutics.">


  <meta name="keywords" content="Raji cells,Transcriptional control,DNA transcription,Cancers and neoplasms,Lymphoma,Transcription factors,Chromatin immunoprecipitation,Elongation factors" />


<meta name="citation_doi" content="10.1371/journal.pone.0087003"/>
<meta name="citation_author" content="Trent Fowler"/>
  <meta name="citation_author_institution" content="Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, United States of America"/>
<meta name="citation_author" content="Payel Ghatak"/>
  <meta name="citation_author_institution" content="Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, United States of America"/>
<meta name="citation_author" content="David H. Price"/>
  <meta name="citation_author_institution" content="Biochemistry Department, University of Iowa, Iowa City, Iowa, United States of America"/>
<meta name="citation_author" content="Ronald Conaway"/>
  <meta name="citation_author_institution" content="Stowers Institute for Medical Research, Kansas City, Missouri, United States of America"/>
<meta name="citation_author" content="Joan Conaway"/>
  <meta name="citation_author_institution" content="Stowers Institute for Medical Research, Kansas City, Missouri, United States of America"/>
<meta name="citation_author" content="Cheng-Ming Chiang"/>
  <meta name="citation_author_institution" content="Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America"/>
<meta name="citation_author" content="James E. Bradner"/>
  <meta name="citation_author_institution" content="Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America"/>
<meta name="citation_author" content="Ali Shilatifard"/>
  <meta name="citation_author_institution" content="Stowers Institute for Medical Research, Kansas City, Missouri, United States of America"/>
<meta name="citation_author" content="Ananda L. Roy"/>
  <meta name="citation_author_institution" content="Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, United States of America"/>
  <meta name="citation_author_institution" content="Program in Genetics, Sackler School of Biomedical Science, Tufts University School of Medicine, Boston, Massachusetts, United States of America"/>
  <meta name="citation_author_institution" content="Program in Immunology, Sackler School of Biomedical Science, Tufts University School of Medicine, Boston, Massachusetts, United States of America"/>

<meta name="citation_title" content="Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells"/>
<meta itemprop="name" content="Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells"/>
<meta name="citation_journal_title" content="PLOS ONE"/>
<meta name="citation_journal_abbrev" content="PLOS ONE"/>
<meta name="citation_date" content="Jan 23, 2014"/>
<meta name="citation_firstpage" content="e87003"/>
<meta name="citation_issue" content="1"/>
<meta name="citation_volume" content="9"/>
<meta name="citation_issn" content="1932-6203"/>
<meta name="citation_publisher" content="Public Library of Science"/>

  <meta name="citation_pdf_url" content="https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0087003&type=printable">

  <meta name="citation_article_type" content="Research Article">

<meta name="dc.identifier" content="10.1371/journal.pone.0087003" />


  <meta name="twitter:card" content="summary" />
  <meta name="twitter:site" content="plosone"/>
    <meta name="twitter:title" content="Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells" />
    <meta property="twitter:description" content="High level MYC expression is associated with almost all human cancers. JQ1, a chemical compound that inhibits MYC expression is therapeutically effective in preclinical animal models in midline carcinoma, and Burkitt&rsquo;s lymphoma (BL). Here we show that JQ1 does not inhibit MYC expression to a similar extent in all tumor cells. The BL cells showed a &sim;90% decrease in MYC transcription upon treatment with JQ1, however, no corresponding reduction was seen in several non-BL cells. Molecularly, these differences appear due to requirements of Brd4, the most active version of the Positive Transcription Elongation Factor B (P-TEFb) within the Super Elongation Complex (SEC), and transcription factors such as Gdown1, and MED26 and also other unknown cell specific factors. Our study demonstrates that the regulation of high levels of MYC expression in different cancer cells is driven by unique regulatory mechanisms and that such exclusive regulatory signatures in each cancer cells could be employed for targeted therapeutics." />
    <meta property="twitter:image" content="https://journals.plos.org/plosone/article/figure/image?id=10.1371/journal.pone.0087003.g004&size=inline" />

<meta property="og:type" content="article" />
<meta property="og:url" content="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0087003"/>
<meta property="og:title" content="Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells"/>
<meta property="og:description" content="High level MYC expression is associated with almost all human cancers. JQ1, a chemical compound that inhibits MYC expression is therapeutically effective in preclinical animal models in midline carcinoma, and Burkitt&rsquo;s lymphoma (BL). Here we show that JQ1 does not inhibit MYC expression to a similar extent in all tumor cells. The BL cells showed a &sim;90% decrease in MYC transcription upon treatment with JQ1, however, no corresponding reduction was seen in several non-BL cells. Molecularly, these differences appear due to requirements of Brd4, the most active version of the Positive Transcription Elongation Factor B (P-TEFb) within the Super Elongation Complex (SEC), and transcription factors such as Gdown1, and MED26 and also other unknown cell specific factors. Our study demonstrates that the regulation of high levels of MYC expression in different cancer cells is driven by unique regulatory mechanisms and that such exclusive regulatory signatures in each cancer cells could be employed for targeted therapeutics."/>
<meta property="og:image" content="https://journals.plos.org/plosone/article/figure/image?id=10.1371/journal.pone.0087003.g004&size=inline"/>

<meta name="citation_reference" content="citation_title=B-cell receptor signaling in the genesis and maintenance of B-cell lymphoma;citation_author=RM Young;citation_author=BC Turner;citation_author=Y Refaeli;citation_journal_title=Future Oncol;citation_volume=4;citation_number=4;citation_first_page=591;citation_last_page=594;citation_publication_date=2008;"/>    
<meta name="citation_reference" content="citation_title=The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas;citation_author=Y Refaeli;citation_author=RM Young;citation_author=BC Turner;citation_author=J Duda;citation_author=KA Field;citation_journal_title=PLoS Biol;citation_volume=6;citation_number=6;citation_first_page=e152;citation_publication_date=2008;"/>    
<meta name="citation_reference" content="citation_title=Pathogenesis of human B cell lymphomas;citation_author=AL Shaffer 3rd;citation_author=RM Young;citation_author=LM Staudt;citation_journal_title=Annu Rev Immunol;citation_volume=30;citation_number=30;citation_first_page=565;citation_last_page=610;citation_publication_date=2012;"/>    
<meta name="citation_reference" content="citation_title=High Myc activity is an independent negative prognostic factor for diffuse large B cell lymphomas;citation_author=A Schrader;citation_author=S Bentink;citation_author=R Spang;citation_author=D Lenze;citation_author=M Hummel;citation_journal_title=Int J Cancer;citation_volume=131;citation_number=131;citation_first_page=E348;citation_last_page=361;citation_publication_date=2012;"/>    
<meta name="citation_reference" content="citation_title=8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC;citation_author=N Ahmadiyeh;citation_author=MM Pomerantz;citation_author=C Grisanzio;citation_author=P Herman;citation_author=L Jia;citation_journal_title=Proc Natl Acad Sci U S A;citation_volume=107;citation_number=107;citation_first_page=9742;citation_last_page=9746;citation_publication_date=2010;"/>    
<meta name="citation_reference" content="citation_title=Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma;citation_author=P Selvanayagam;citation_author=M Blick;citation_author=F Narni;citation_author=P van Tuinen;citation_author=DH Ledbetter;citation_journal_title=Blood;citation_volume=71;citation_number=71;citation_first_page=30;citation_last_page=35;citation_publication_date=1988;"/>    
<meta name="citation_reference" content="citation_title=MYC on the path to cancer;citation_author=CV Dang;citation_journal_title=Cell;citation_volume=149;citation_number=149;citation_first_page=22;citation_last_page=35;citation_publication_date=2012;"/>    
<meta name="citation_reference" content="citation_title=Transcriptional amplification in tumor cells with elevated c-Myc;citation_author=CY Lin;citation_author=J Loven;citation_author=PB Rahl;citation_author=RM Paranal;citation_author=CB Burge;citation_journal_title=Cell;citation_volume=151;citation_number=151;citation_first_page=56;citation_last_page=67;citation_publication_date=2012;"/>    
<meta name="citation_reference" content="citation_title=c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells;citation_author=Z Nie;citation_author=G Hu;citation_author=G Wei;citation_author=K Cui;citation_author=A Yamane;citation_journal_title=Cell;citation_volume=151;citation_number=151;citation_first_page=68;citation_last_page=79;citation_publication_date=2012;"/>    
<meta name="citation_reference" content="citation_title=Regulation of primary response genes;citation_author=T Fowler;citation_author=R Sen;citation_author=AL Roy;citation_journal_title=Mol Cell;citation_volume=44;citation_number=44;citation_first_page=348;citation_last_page=360;citation_publication_date=2011;"/>    
<meta name="citation_reference" content="citation_title=Bromodomains as therapeutic targets;citation_author=S Muller;citation_author=P Filippakopoulos;citation_author=S Knapp;citation_journal_title=Expert Rev Mol Med;citation_volume=13;citation_number=13;citation_first_page=e29;citation_publication_date=2011;"/>    
<meta name="citation_reference" content="citation_title=The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis;citation_author=A Dey;citation_author=F Chitsaz;citation_author=A Abbasi;citation_author=T Misteli;citation_author=K Ozato;citation_journal_title=Proc Natl Acad Sci U S A;citation_volume=100;citation_number=100;citation_first_page=8758;citation_last_page=8763;citation_publication_date=2003;"/>    
<meta name="citation_reference" content="citation_title=RNA polymerase II elongation control;citation_author=Q Zhou;citation_author=T Li;citation_author=DH Price;citation_journal_title=Annu Rev Biochem;citation_volume=81;citation_number=81;citation_first_page=119;citation_last_page=143;citation_publication_date=2012;"/>    
<meta name="citation_reference" content="citation_title=RNA Polymerase II Transcription Elongation Control. Chem Rev;citation_author=J Guo;citation_author=DH Price;citation_volume=113;citation_number=113;citation_first_page=8583;citation_last_page=603;citation_publication_date=2013;"/>    

<meta name="citation_reference" content="Miyoshi S, Ooike S, Iwata K, Hikawa H, Sugaraha K (2009). International Patent No. PCT/JP2008/073864 (WO/2009/084693)."/>
<meta name="citation_reference" content="citation_title=BET bromodomain inhibition as a therapeutic strategy to target c-Myc;citation_author=JE Delmore;citation_author=GC Issa;citation_author=ME Lemieux;citation_author=PB Rahl;citation_author=J Shi;citation_journal_title=Cell;citation_volume=146;citation_number=146;citation_first_page=904;citation_last_page=917;citation_publication_date=2011;"/>    
<meta name="citation_reference" content="citation_title=Selective inhibition of BET bromodomains;citation_author=P Filippakopoulos;citation_author=J Qi;citation_author=S Picaud;citation_author=Y Shen;citation_author=WB Smith;citation_journal_title=Nature;citation_volume=468;citation_number=468;citation_first_page=1067;citation_last_page=1073;citation_publication_date=2010;"/>    
<meta name="citation_reference" content="citation_title=Suppression of inflammation by a synthetic histone mimic;citation_author=E Nicodeme;citation_author=KL Jeffrey;citation_author=U Schaefer;citation_author=S Beinke;citation_author=S Dewell;citation_journal_title=Nature;citation_volume=468;citation_number=468;citation_first_page=1119;citation_last_page=1123;citation_publication_date=2010;"/>    
<meta name="citation_reference" content="citation_title=Targeting MYC dependence in cancer by inhibiting BET bromodomains;citation_author=JA Mertz;citation_author=AR Conery;citation_author=BM Bryant;citation_author=P Sandy;citation_author=S Balasubramanian;citation_journal_title=Proc Natl Acad Sci U S A;citation_volume=108;citation_number=108;citation_first_page=16669;citation_last_page=16674;citation_publication_date=2011;"/>    
<meta name="citation_reference" content="citation_title=Establishment and characterization of BALB/c lymphoma lines with B cell properties;citation_author=KJ Kim;citation_author=C Kanellopoulos-Langevin;citation_author=RM Merwin;citation_author=DH Sachs;citation_author=R Asofsky;citation_journal_title=J Immunol;citation_volume=122;citation_number=122;citation_first_page=549;citation_last_page=554;citation_publication_date=1979;"/>    
<meta name="citation_reference" content="citation_title=Synchronous and sequential activation of latently infected Epstein-Barr virus genomes;citation_author=K Takada;citation_author=Y Ono;citation_journal_title=J Virol;citation_volume=63;citation_number=63;citation_first_page=445;citation_last_page=449;citation_publication_date=1989;"/>    
<meta name="citation_reference" content="citation_title=Cytology of Burkitt’s Tumour (African Lymphoma);citation_author=JV Pulvertaft;citation_journal_title=Lancet;citation_volume=1;citation_number=1;citation_first_page=238;citation_last_page=240;citation_publication_date=1964;"/>    
<meta name="citation_reference" content="citation_title=Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA;citation_author=GB Clements;citation_author=G Klein;citation_author=S Povey;citation_journal_title=Int J Cancer;citation_volume=16;citation_number=16;citation_first_page=125;citation_last_page=133;citation_publication_date=1975;"/>    
<meta name="citation_reference" content="citation_title=Genetics of Somatic Mammalian Cells: I. Demonstration of the Existence of Mutants with Different Growth Requirements in a Human Cancer Cell Strain (Hela);citation_author=TT Puck;citation_author=HW Fisher;citation_journal_title=J Exp Med;citation_volume=104;citation_number=104;citation_first_page=427;citation_last_page=434;citation_publication_date=1956;"/>    
<meta name="citation_reference" content="citation_title=Regulation of primary response genes in B cells;citation_author=T Fowler;citation_author=H Suh;citation_author=S Buratowski;citation_author=AL Roy;citation_journal_title=J Biol Chem;citation_volume=288;citation_number=288;citation_first_page=14906;citation_last_page=14916;citation_publication_date=2013;"/>    
<meta name="citation_reference" content="citation_title=Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting;citation_author=SY Wu;citation_author=AY Lee;citation_author=HT Lai;citation_author=H Zhang;citation_author=CM Chiang;citation_journal_title=Mol Cell;citation_volume=49;citation_number=49;citation_first_page=843;citation_last_page=857;citation_publication_date=2013;"/>    
<meta name="citation_reference" content="citation_title=Brd4 links chromatin targeting to HPV transcriptional silencing;citation_author=SY Wu;citation_author=AY Lee;citation_author=SY Hou;citation_author=JK Kemper;citation_author=H Erdjument-Bromage;citation_journal_title=Genes Dev;citation_volume=20;citation_number=20;citation_first_page=2383;citation_last_page=2396;citation_publication_date=2006;"/>    
<meta name="citation_reference" content="citation_title=Functional association of Gdown1 with RNA polymerase II poised on human genes;citation_author=B Cheng;citation_author=T Li;citation_author=PB Rahl;citation_author=TE Adamson;citation_author=NB Loudas;citation_journal_title=Mol Cell;citation_volume=45;citation_number=45;citation_first_page=38;citation_last_page=50;citation_publication_date=2012;"/>    
<meta name="citation_reference" content="citation_title=AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia;citation_author=C Lin;citation_author=ER Smith;citation_author=H Takahashi;citation_author=KC Lai;citation_author=S Martin-Brown;citation_journal_title=Mol Cell;citation_volume=37;citation_number=37;citation_first_page=429;citation_last_page=437;citation_publication_date=2010;"/>    
<meta name="citation_reference" content="citation_title=Expression of cellular myc and mos genes in undifferentiated B cell lymphomas of Burkitt and non-Burkitt types;citation_author=RT Maguire;citation_author=TS Robins;citation_author=SS Thorgeirsson;citation_author=CA Heilman;citation_journal_title=Proc Natl Acad Sci U S A;citation_volume=80;citation_number=80;citation_first_page=1947;citation_last_page=1950;citation_publication_date=1983;"/>    
<meta name="citation_reference" content="citation_title=Transcript dynamics of proinflammatory genes revealed by sequence analysis of subcellular RNA fractions;citation_author=DM Bhatt;citation_author=A Pandya-Jones;citation_author=AJ Tong;citation_author=I Barozzi;citation_author=MM Lissner;citation_journal_title=Cell;citation_volume=150;citation_number=150;citation_first_page=279;citation_last_page=290;citation_publication_date=2012;"/>    
<meta name="citation_reference" content="citation_title=Divergent transcription: a new feature of active promoters;citation_author=AC Seila;citation_author=LJ Core;citation_author=JT Lis;citation_author=PA Sharp;citation_journal_title=Cell Cycle;citation_volume=8;citation_number=8;citation_first_page=2557;citation_last_page=2564;citation_publication_date=2009;"/>    
<meta name="citation_reference" content="citation_title=Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands;citation_author=MJ Klemsz;citation_author=LB Justement;citation_author=E Palmer;citation_author=JC Cambier;citation_journal_title=J Immunol;citation_volume=143;citation_number=143;citation_first_page=1032;citation_last_page=1039;citation_publication_date=1989;"/>    
<meta name="citation_reference" content="citation_title=Cell-type specific and combinatorial usage of diverse transcription factors revealed by genome-wide binding studies in multiple human cells;citation_author=BK Lee;citation_author=AA Bhinge;citation_author=A Battenhouse;citation_author=RM McDaniell;citation_author=Z Liu;citation_journal_title=Genome Res;citation_volume=22;citation_number=22;citation_first_page=9;citation_last_page=24;citation_publication_date=2012;"/>    
<meta name="citation_reference" content="citation_title=Pausing of RNA polymerase II disrupts DNA-specified nucleosome organization to enable precise gene regulation;citation_author=DA Gilchrist;citation_author=G Dos Santos;citation_author=DC Fargo;citation_author=B Xie;citation_author=Y Gao;citation_journal_title=Cell;citation_volume=143;citation_number=143;citation_first_page=540;citation_last_page=551;citation_publication_date=2010;"/>    
<meta name="citation_reference" content="citation_title=The CTD code;citation_author=S Buratowski;citation_journal_title=Nat Struct Biol;citation_volume=10;citation_number=10;citation_first_page=679;citation_last_page=680;citation_publication_date=2003;"/>    
<meta name="citation_reference" content="citation_title=Progression through the RNA polymerase II CTD cycle;citation_author=S Buratowski;citation_journal_title=Mol Cell;citation_volume=36;citation_number=36;citation_first_page=541;citation_last_page=546;citation_publication_date=2009;"/>    
<meta name="citation_reference" content="citation_title=Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes;citation_author=D Biswas;citation_author=TA Milne;citation_author=V Basrur;citation_author=J Kim;citation_author=KS Elenitoba-Johnson;citation_journal_title=Proc Natl Acad Sci U S A;citation_volume=108;citation_number=108;citation_first_page=15751;citation_last_page=15756;citation_publication_date=2011;"/>    
<meta name="citation_reference" content="citation_title=The super elongation complex family of RNA polymerase II elongation factors: gene target specificity and transcriptional output;citation_author=Z Luo;citation_author=C Lin;citation_author=E Guest;citation_author=AS Garrett;citation_author=N Mohaghegh;citation_journal_title=Mol Cell Biol;citation_volume=32;citation_number=32;citation_first_page=2608;citation_last_page=2617;citation_publication_date=2012;"/>    
<meta name="citation_reference" content="citation_title=The super elongation complex (SEC) family in transcriptional control;citation_author=Z Luo;citation_author=C Lin;citation_author=A Shilatifard;citation_journal_title=Nat Rev Mol Cell Biol;citation_volume=13;citation_number=13;citation_first_page=543;citation_last_page=547;citation_publication_date=2012;"/>    
<meta name="citation_reference" content="citation_title=Human mediator subunit MED26 functions as a docking site for transcription elongation factors;citation_author=H Takahashi;citation_author=TJ Parmely;citation_author=S Sato;citation_author=C Tomomori-Sato;citation_author=CA Banks;citation_journal_title=Cell;citation_volume=146;citation_number=146;citation_first_page=92;citation_last_page=104;citation_publication_date=2011;"/>    
<meta name="citation_reference" content="citation_title=A Mediator-responsive form of metazoan RNA polymerase II;citation_author=X Hu;citation_author=S Malik;citation_author=CC Negroiu;citation_author=K Hubbard;citation_author=CN Velalar;citation_journal_title=Proc Natl Acad Sci U S A;citation_volume=103;citation_number=103;citation_first_page=9506;citation_last_page=9511;citation_publication_date=2006;"/>    
<meta name="citation_reference" content="citation_title=Level of MYC overexpression in pediatric Burkitt’s lymphoma is strongly dependent on genomic breakpoint location within the MYC locus;citation_author=M Wilda;citation_author=K Busch;citation_author=I Klose;citation_author=T Keller;citation_author=W Woessmann;citation_journal_title=Genes Chromosomes Cancer;citation_volume=41;citation_number=41;citation_first_page=178;citation_last_page=182;citation_publication_date=2004;"/>    

<meta name="citation_reference" content="Kellner WA, Van Bortle K, Li L, Ramos E, Takenaka N,  et al .. (2013) Distinct isoforms of the Drosophila Brd4 homologue are present at enhancers, promoters and insulator sites. Nucleic Acids Res."/>
<meta name="citation_reference" content="citation_title=Selective inhibition of tumor oncogenes by disruption of super-enhancers;citation_author=J Loven;citation_author=HA Hoke;citation_author=CY Lin;citation_author=A Lau;citation_author=DA Orlando;citation_journal_title=Cell;citation_volume=153;citation_number=153;citation_first_page=320;citation_last_page=334;citation_publication_date=2013;"/>    
<meta name="citation_reference" content="citation_title=Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells;citation_author=W Zhang;citation_author=C Prakash;citation_author=C Sum;citation_author=Y Gong;citation_author=Y Li;citation_journal_title=J Biol Chem;citation_volume=287;citation_number=287;citation_first_page=43137;citation_last_page=43155;citation_publication_date=2012;"/>    
<meta name="citation_reference" content="citation_title=7SK snRNA: a noncoding RNA that plays a major role in regulating eukaryotic transcription;citation_author=BM Peterlin;citation_author=JE Brogie;citation_author=DH Price;citation_journal_title=Wiley Interdiscip Rev RNA;citation_volume=3;citation_number=3;citation_first_page=92;citation_last_page=103;citation_publication_date=2012;"/>    
<meta name="citation_reference" content="citation_title=Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein;citation_author=K Bartholomeeusen;citation_author=Y Xiang;citation_author=K Fujinaga;citation_author=BM Peterlin;citation_journal_title=J Biol Chem;citation_volume=287;citation_number=287;citation_first_page=36609;citation_last_page=36616;citation_publication_date=2012;"/>    
<meta name="citation_reference" content="citation_title=You Don’t Muck with MYC;citation_author=D Levens;citation_journal_title=Genes Cancer;citation_volume=1;citation_number=1;citation_first_page=547;citation_last_page=554;citation_publication_date=2010;"/>    
<meta name="citation_reference" content="citation_title=Constitutive C-myc overexpression and p1/p2 promoter shift in a small-cell lung-cancer cell-line;citation_author=S Dooley;citation_author=I Wundrack;citation_author=C Welter;citation_author=N Blin;citation_journal_title=Int J Oncol;citation_volume=5;citation_number=5;citation_first_page=65;citation_last_page=68;citation_publication_date=1994;"/>    
<meta name="citation_reference" content="citation_title=Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis;citation_author=M Mohan;citation_author=C Lin;citation_author=E Guest;citation_author=A Shilatifard;citation_journal_title=Nat Rev Cancer;citation_volume=10;citation_number=10;citation_first_page=721;citation_last_page=728;citation_publication_date=2010;"/>    
<meta name="citation_reference" content="citation_title=Paused RNA polymerase II as a developmental checkpoint;citation_author=M Levine;citation_journal_title=Cell;citation_volume=145;citation_number=145;citation_first_page=502;citation_last_page=511;citation_publication_date=2011;"/>    
<meta name="citation_reference" content="citation_title=Global analysis of short RNAs reveals widespread promoter-proximal stalling and arrest of Pol II in Drosophila;citation_author=S Nechaev;citation_author=DC Fargo;citation_author=G dos Santos;citation_author=L Liu;citation_author=Y Gao;citation_journal_title=Science;citation_volume=327;citation_number=327;citation_first_page=335;citation_last_page=338;citation_publication_date=2010;"/>    


<!-- DoubleClick overall ad setup script -->
<script type='text/javascript'>
  var googletag = googletag || {};
  googletag.cmd = googletag.cmd || [];
  (function() {
    var gads = document.createElement('script');
    gads.async = true;
    gads.type = 'text/javascript';
    var useSSL = 'https:' == document.location.protocol;
    gads.src = (useSSL ? 'https:' : 'http:') +
        '//www.googletagservices.com/tag/js/gpt.js';
    var node = document.getElementsByTagName('script')[0];
    node.parentNode.insertBefore(gads, node);
  })();
</script>

<!-- DoubleClick ad slot setup script -->

  <script id="doubleClickSetupScript" type='text/javascript'>
    googletag.cmd.push(function() {
  googletag.defineSlot('/75507958/PONE_728x90_ATF', [728, 90], 'div-gpt-ad-1458247671871-0').addService(googletag.pubads());
  googletag.defineSlot('/75507958/PONE_160x600_BTF', [160, 600], 'div-gpt-ad-1458247671871-1').addService(googletag.pubads());
      var personalizedAds = window.plosCookieConsent && window.plosCookieConsent.hasConsented('advertising');
      googletag.pubads().setRequestNonPersonalizedAds(personalizedAds ? 0 : 1);
      googletag.pubads().enableSingleRequest();
      googletag.enableServices();
    });
  </script>



<script type="text/javascript">
    var WombatConfig = WombatConfig || {};
    WombatConfig.journalKey = "PLoSONE";
    WombatConfig.figurePath = "/plosone/article/figure/image";
    WombatConfig.figShareInstitutionString = "plos";
    WombatConfig.doiResolverPrefix = "https://dx.plos.org/";
</script>

<script type="text/javascript">
  var WombatConfig = WombatConfig || {};
  WombatConfig.metrics = WombatConfig.metrics || {};
  WombatConfig.metrics.referenceUrl      = "http://lagotto.io/plos";
  WombatConfig.metrics.googleScholarUrl  = "https://scholar.google.com/scholar";
  WombatConfig.metrics.googleScholarCitationUrl  = WombatConfig.metrics.googleScholarUrl + "?hl=en&lr=&q=";
  WombatConfig.metrics.crossrefUrl  = "https://www.crossref.org";
</script>
<script defer="defer" src="/resource/js/defer.js?df22e765dd76f625eb58"></script><script src="/resource/js/sync.js?df22e765dd76f625eb58"></script>
<script src="https://ajax.googleapis.com/ajax/libs/jquery/2.1.4/jquery.min.js"></script>

          <script type="text/javascript" src="https://widgets.figshare.com/static/figshare.js"></script>

<script src="/resource/js/vendor/fastclick/lib/fastclick.js" type="text/javascript"></script>
<script src="/resource/js/vendor/foundation/foundation.js" type="text/javascript"></script>
<script src="/resource/js/vendor/underscore-min.js" type="text/javascript"></script>
<script src="/resource/js/vendor/underscore.string.min.js" type="text/javascript"></script>
<script src="/resource/js/vendor/moment.js" type="text/javascript"></script>


<script src="/resource/js/vendor/jquery-ui-effects.min.js" type="text/javascript"></script>

<script src="/resource/js/vendor/foundation/foundation.tooltip.js" type="text/javascript"></script>
<script src="/resource/js/vendor/foundation/foundation.dropdown.js" type="text/javascript"></script>
<script src="/resource/js/vendor/foundation/foundation.tab.js" type="text/javascript"></script>
<script src="/resource/js/vendor/foundation/foundation.reveal.js" type="text/javascript"></script>
<script src="/resource/js/vendor/foundation/foundation.slider.js" type="text/javascript"></script>

<script src="/resource/js/util/utils.js" type="text/javascript"></script>
<script src="/resource/js/components/toggle.js" type="text/javascript"></script>
<script src="/resource/js/components/truncate_elem.js" type="text/javascript"></script>
<script src="/resource/js/components/tooltip_hover.js" type="text/javascript"></script>
<script src="/resource/js/vendor/jquery.dotdotdot.js" type="text/javascript"></script>

<!--For Google Tag manager to be able to track site information  -->
<script>

  dataLayer = [{
    'mobileSite': 'false',
    'desktopSite': 'true'
  }];

</script>

</head>

<body class="article plosone">


<!-- Google Tag Manager -->
<script>
  var gaDisable = 'ga-disable-UA-76325259-';
  var consented = !(window.plosCookieConsent && window.plosCookieConsent.hasConsented('analytics'));
  for(var i=0;i<100;i++) { //This will break if we ever support 100+ journals (*insert Oh no! Anyway... meme*)
    window[gaDisable + i] = consented;
  }
</script>
<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-TP26BH"
                  height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<script>
  (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
    new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
    j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
    '//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-TP26BH');
</script>

<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-MQQMGF"
                  height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
    new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
    j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
    '//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-MQQMGF');</script>
<!-- End Google Tag Manager -->

<!-- New Relic -->
<script type="text/javascript">
  ;window.NREUM||(NREUM={});NREUM.init={distributed_tracing:{enabled:true},privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]}};
  window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{s.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(32),s={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(s.console=!0,o.indexOf("dev")!==-1&&(s.dev=!0),o.indexOf("nr_dev")!==-1&&(s.nrDev=!0))}catch(c){}s.nrDev&&i.on("internal-error",function(t){r(t.stack)}),s.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),s.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(s,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,s){try{l?l-=1:o(s||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,c.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:c.now();i("err",[t,n])}var i=t("handle"),a=t(33),s=t("ee"),c=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError";if(!c.disabled){var l=0;c.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(14),t(13),"addEventListener"in window&&t(7),c.xhrWrappable&&t(15),d=!0)}s.on("fn-start",function(t,e,n){d&&(l+=1)}),s.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),s.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),s.on("internal-error",function(t){i("ierr",[t,c.now(),!0])})}},{}],3:[function(t,e,n){var r=t("loader");r.disabled||(r.features.ins=!0)},{}],4:[function(t,e,n){function r(){U++,L=g.hash,this[u]=y.now()}function o(){U--,g.hash!==L&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var s="-start",c="-end",f="-body",u="fn"+s,d="fn"+c,p="cb"+s,l="cb"+c,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable&&!y.disabled){var x=t(11),b=t(12),E=t(9),R=t(7),O=t(14),T=t(8),P=t(15),S=t(10),M=t("ee"),N=M.get("tracer"),C=t(23);t(17),y.features.spa=!0;var L,U=0;M.on(u,r),b.on(p,r),S.on(p,r),M.on(d,o),b.on(l,o),S.on(l,o),M.buffer([u,d,"xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+c,"clearTimeout"+s,u]),P.buffer([u,"new-xhr","send-xhr"+s]),T.buffer([m+s,m+"-done",m+f+s,m+f+c]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+s]),N.buffer([u,"no-"+u]),S.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(T,m+s),a(T,m+"-done"),a(S,"new-jsonp"),a(S,"jsonp-end"),a(S,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,C(!0)),w[v]("load",i,C(!0)),w[v]("popstate",function(){i(0,U>1)},C(!0))}},{}],5:[function(t,e,n){function r(){var t=new PerformanceObserver(function(t,e){var n=t.getEntries();s(v,[n])});try{t.observe({entryTypes:["resource"]})}catch(e){}}function o(t){if(s(v,[window.performance.getEntriesByType(w)]),window.performance["c"+p])try{window.performance[h](m,o,!1)}catch(t){}else try{window.performance[h]("webkit"+m,o,!1)}catch(t){}}function i(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var a=t("ee"),s=t("handle"),c=t(14),f=t(13),u=t(6),d=t(23),p="learResourceTimings",l="addEventListener",h="removeEventListener",m="resourcetimingbufferfull",v="bstResource",w="resource",g="-start",y="-end",x="fn"+g,b="fn"+y,E="bstTimer",R="pushState",O=t("loader");if(!O.disabled){O.features.stn=!0,t(9),"addEventListener"in window&&t(7);var T=NREUM.o.EV;a.on(x,function(t,e){var n=t[0];n instanceof T&&(this.bstStart=O.now())}),a.on(b,function(t,e){var n=t[0];n instanceof T&&s("bst",[n,e,this.bstStart,O.now()])}),c.on(x,function(t,e,n){this.bstStart=O.now(),this.bstType=n}),c.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),this.bstType])}),f.on(x,function(){this.bstStart=O.now()}),f.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),"requestAnimationFrame"])}),a.on(R+g,function(t){this.time=O.now(),this.startPath=location.pathname+location.hash}),a.on(R+y,function(t){s("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),u()?(s(v,[window.performance.getEntriesByType("resource")]),r()):l in window.performance&&(window.performance["c"+p]?window.performance[l](m,o,d(!1)):window.performance[l]("webkit"+m,o,d(!1))),document[l]("scroll",i,d(!1)),document[l]("keypress",i,d(!1)),document[l]("click",i,d(!1))}}},{}],6:[function(t,e,n){e.exports=function(){return"PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver}},{}],7:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){s.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),s=t("wrap-function")(a,!0),c=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1];if(null!==n&&("function"==typeof n||"object"==typeof n)){var r=c(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?s(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],8:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var s=r.apply(this,t);return o.emit(n+"start",[t,a],s),s.then(function(t){return o.emit(n+"end",[null,t],s),t},function(t){throw o.emit(n+"end",[t],s),t})})}var o=t("ee").get("fetch"),i=t(33),a=t(32);e.exports=o;var s=window,c="fetch-",f=c+"body-",u=["arrayBuffer","blob","json","text","formData"],d=s.Request,p=s.Response,l=s.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(s,"fetch",c),o.on(c+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(c+"done",[null,e],n)}else o.emit(c+"done",[t],n)}))},{}],9:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],10:[function(t,e,n){function r(t){function e(){f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}function n(){f.emit("jsonp-error",[],l),f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var d=s(a),p="function"==typeof d.parent[d.key];if(p){var l={};u.inPlace(d.parent,[d.key],"cb-",l),t.addEventListener("load",e,c(!1)),t.addEventListener("error",n,c(!1)),f.emit("new-jsonp",[t.src],l)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(d);return e?e[1]:null}function a(t,e){var n=t.match(l),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function s(t){var e=t.match(p);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var c=t(23),f=t("ee").get("jsonp"),u=t("wrap-function")(f);if(e.exports=f,o()){var d=/[?&](?:callback|cb)=([^&#]+)/,p=/(.*)\.([^.]+)/,l=/^(\w+)(\.|$)(.*)$/,h=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?u.inPlace(Node.prototype,h,"dom-"):(u.inPlace(HTMLElement.prototype,h,"dom-"),u.inPlace(HTMLHeadElement.prototype,h,"dom-"),u.inPlace(HTMLBodyElement.prototype,h,"dom-")),f.on("dom-start",function(t){r(t[0])})}},{}],11:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],12:[function(t,e,n){function r(t){var e=i.context(),n=s(t,"executor-",e,null,!1),r=new f(n);return i.context(r).getCtx=function(){return e},r}var o=t("wrap-function"),i=t("ee").get("promise"),a=t("ee").getOrSetContext,s=o(i),c=t(32),f=NREUM.o.PR;e.exports=i,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){i.emit("propagate",[null,!o],a,!1,!1),o=o||!t}}var o=!1;c(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var a=e.apply(f,arguments),s=f.resolve(a);return s}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&i.emit("propagate",[t,!0],n,!1,!1),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),c(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),o.wrapInPlace(f.prototype,"then",function(t){return function(){var e=this,n=o.argsToArray.apply(this,arguments),r=a(e);r.promise=e,n[0]=s(n[0],"cb-",r,null,!1),n[1]=s(n[1],"cb-",r,null,!1);var c=t.apply(this,n);return r.nextPromise=c,i.emit("propagate",[e,!0],c,!1,!1),c}}),i.on("executor-start",function(t){t[0]=s(t[0],"resolve-",this,null,!1),t[1]=s(t[1],"resolve-",this,null,!1)}),i.on("executor-err",function(t,e,n){t[1](n)}),i.on("cb-end",function(t,e,n){i.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),i.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=i.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],13:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],14:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),s="setTimeout",c="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[s,"setImmediate"],s+d),a.inPlace(window,[c],c+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(c+u,r),i.on(s+u,o)},{}],15:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",s)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,y,"fn-",s)}function i(t){x.push(t),m&&(E?E.then(a):w?w(a):(R=-R,O.data=R))}function a(){for(var t=0;t<x.length;t++)r([],x[t]);x.length&&(x=[])}function s(t,e){return e}function c(t,e){for(var n in t)e[n]=t[n];return e}t(7);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=t(23),l=NREUM.o,h=l.XHR,m=l.MO,v=l.PR,w=l.SI,g="readystatechange",y=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],x=[];e.exports=u;var b=window.XMLHttpRequest=function(t){var e=new h(t);try{u.emit("new-xhr",[e],e),e.addEventListener(g,o,p(!1))}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(c(h,b),b.prototype=h.prototype,d.inPlace(b.prototype,["open","send"],"-xhr-",s),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),m){var E=v&&v.resolve();if(!w&&!v){var R=1,O=document.createTextNode(R);new m(a).observe(O,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===g||a()})},{}],16:[function(t,e,n){function r(t){if(!s(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||c(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&c(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",s=1,c="",f="";return o+"@nr="+i+"-"+s+"-"+n+"-"+r+"-"+t+"-"+a+"-"+c+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var s={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(s.d.tk=i),btoa(JSON.stringify(s))}function s(t){return f()&&c(t)}function c(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(29),h=t(18);e.exports={generateTracePayload:r,shouldGenerateTrace:s}},{}],17:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,s("xhr",[e,n,this.startTime,this.endTime,"xhr"],this))}}function o(t,e){var n=c(e),r=t.params;r.hostname=n.hostname,r.port=n.port,r.protocol=n.protocol,r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=n,t.sameOrigin=n.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable&&!a.disabled){var s=t("handle"),c=t(18),f=t(16).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(24),m=t(22),v=t(19),w=t(23),g=NREUM.o.REQ,y=window.XMLHttpRequest;a.features.xhr=!0,t(15),t(8),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,e.params=this.params||{},e.metrics=this.metrics||{},t.addEventListener("load",function(n){i(e,t)},w(!1)),h&&(h>34||h<10)||t.addEventListener("progress",function(t){e.lastSize=t.loaded},w(!1))}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var s=0;s<p;s++)e.addEventListener(d[s],this.listener,w(!1))}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("xhr-resolved",function(){this.endTime=a.now()}),u.on("addEventListener-end",function(t,e){e instanceof y&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof y&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof y&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url?n=t[0].url:window.URL&&t[0]&&t[0]instanceof URL&&(n=t[0].href),n&&(this.parsedOrigin=c(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]||window.URL&&t[0]&&t[0]instanceof URL){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)}),u.on("fetch-start",function(t,e){this.params={},this.metrics={},this.startTime=a.now(),this.dt=e,t.length>=1&&(this.target=t[0]),t.length>=2&&(this.opts=t[1]);var n,r=this.opts||{},i=this.target;"string"==typeof i?n=i:"object"==typeof i&&i instanceof g?n=i.url:window.URL&&"object"==typeof i&&i instanceof URL&&(n=i.href),o(this,n);var s=(""+(i&&i instanceof g&&i.method||r.method||"GET")).toUpperCase();this.params.method=s,this.txSize=m(r.body)||0}),u.on("fetch-done",function(t,e){this.endTime=a.now(),this.params||(this.params={}),this.params.status=e?e.status:0;var n;"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var r={txSize:this.txSize,rxSize:n,duration:a.now()-this.startTime};s("xhr",[this.params,r,this.startTime,this.endTime,"fetch"],this)})}},{}],18:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,s=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||s),"/"===o.pathname&&(r[t]=o),o}},{}],19:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(22);e.exports=r},{}],20:[function(t,e,n){function r(){}function o(t,e,n,r){return function(){return u.recordSupportability("API/"+e+"/called"),i(t+e,[f.now()].concat(s(arguments)),n?null:this,r),n?void 0:this}}var i=t("handle"),a=t(32),s=t(33),c=t("ee").get("tracer"),f=t("loader"),u=t(25),d=NREUM;"undefined"==typeof window.newrelic&&(newrelic=d);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",h=l+"ixn-";a(p,function(t,e){d[e]=o(l,e,!0,"api")}),d.addPageAction=o(l,"addPageAction",!0),d.setCurrentRouteName=o(l,"routeName",!0),e.exports=newrelic,d.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(h+"tracer",[f.now(),t,n],r),function(){if(c.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw c.emit("fn-err",[arguments,this,t],n),t}finally{c.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){m[e]=o(h,e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),u.recordSupportability("API/noticeError/called"),i("err",[t,f.now(),!1,e])}},{}],21:[function(t,e,n){function r(t){if(NREUM.init){for(var e=NREUM.init,n=t.split("."),r=0;r<n.length-1;r++)if(e=e[n[r]],"object"!=typeof e)return;return e=e[n[n.length-1]]}}e.exports={getConfiguration:r}},{}],22:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],23:[function(t,e,n){var r=!1;try{var o=Object.defineProperty({},"passive",{get:function(){r=!0}});window.addEventListener("testPassive",null,o),window.removeEventListener("testPassive",null,o)}catch(i){}e.exports=function(t){return r?{passive:!0,capture:!!t}:!!t}},{}],24:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],25:[function(t,e,n){function r(t,e){var n=[a,t,{name:t},e];return i("storeMetric",n,null,"api"),n}function o(t,e){var n=[s,t,{name:t},e];return i("storeEventMetrics",n,null,"api"),n}var i=t("handle"),a="sm",s="cm";e.exports={constants:{SUPPORTABILITY_METRIC:a,CUSTOM_METRIC:s},recordSupportability:r,recordCustom:o}},{}],26:[function(t,e,n){function r(){return s.exists&&performance.now?Math.round(performance.now()):(i=Math.max((new Date).getTime(),i))-a}function o(){return i}var i=(new Date).getTime(),a=i,s=t(34);e.exports=r,e.exports.offset=a,e.exports.getLastTimestamp=o},{}],27:[function(t,e,n){function r(t){return!(!t||!t.protocol||"file:"===t.protocol)}e.exports=r},{}],28:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?p("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&p("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();if(n.length>0){var r=n[n.length-1];if(c&&c<r.startTime)return;p("lcp",[r])}}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||p("cls",[t])})}function a(t){if(t instanceof v&&!g){var e=Math.round(t.timeStamp),n={type:t.type};e<=l.now()?n.fid=l.now()-e:e>l.offset&&e<=Date.now()?(e-=l.offset,n.fid=l.now()-e):e=l.now(),g=!0,p("timing",["fi",e,n])}}function s(t){"hidden"===t&&(c=l.now(),p("pageHide",[c]))}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var c,f,u,d,p=t("handle"),l=t("loader"),h=t(31),m=t(23),v=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){f=new PerformanceObserver(r);try{f.observe({entryTypes:["paint"]})}catch(w){}u=new PerformanceObserver(o);try{u.observe({entryTypes:["largest-contentful-paint"]})}catch(w){}d=new PerformanceObserver(i);try{d.observe({type:"layout-shift",buffered:!0})}catch(w){}}if("addEventListener"in document){var g=!1,y=["click","keydown","mousedown","pointerdown","touchstart"];y.forEach(function(t){document.addEventListener(t,a,m(!1))})}h(s)}},{}],29:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",s=0;s<i.length;s++)o=i[s],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(31)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],30:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var s=navigator.userAgent,c=s.match(a);c&&s.indexOf("Chrome")===-1&&s.indexOf("Chromium")===-1&&(o="Safari",i=c[1])}e.exports={agent:o,version:i,match:r}},{}],31:[function(t,e,n){function r(t){function e(){t(s&&document[s]?document[s]:document[i]?"hidden":"visible")}"addEventListener"in document&&a&&document.addEventListener(a,e,o(!1))}var o=t(23);e.exports=r;var i,a,s;"undefined"!=typeof document.hidden?(i="hidden",a="visibilitychange",s="visibilityState"):"undefined"!=typeof document.msHidden?(i="msHidden",a="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(i="webkitHidden",a="webkitvisibilitychange",s="webkitVisibilityState")},{}],32:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],33:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],34:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?f(t,c,a):a()}function n(n,r,o,i,a){if(a!==!1&&(a=!0),!l.aborted||i){t&&a&&t(n,r,o);for(var s=e(o),c=m(n),f=c.length,u=0;u<f;u++)c[u].apply(s,r);var p=d[y[n]];return p&&p.push([x,n,r,s]),s}}function i(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return p[t]=p[t]||o(n)}function w(t,e){l.aborted||u(t,function(t,n){e=e||"feature",y[n]=e,e in d||(d[e]=[])})}var g={},y={},x={on:i,addEventListener:i,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:s,aborted:!1};return x}function i(t){return f(t,c,a)}function a(){return new r}function s(){(d.api||d.feature)&&(l.aborted=!0,d=l.backlog={})}var c="nr@context",f=t("gos"),u=t(32),d={},p={},l=e.exports=o();e.exports.getOrSetContext=i,l.backlog=d},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!P++){var t=T.info=NREUM.info,e=v.getElementsByTagName("script")[0];if(setTimeout(f.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return f.abort();c(R,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+T.offset],null,"api"),s("timing",["load",n]);var r=v.createElement("script");0===t.agent.indexOf("http://")||0===t.agent.indexOf("https://")?r.src=t.agent:r.src=h+"://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===v.readyState&&i()}function i(){s("mark",["domContent",a()+T.offset],null,"api")}var a=t(26),s=t("handle"),c=t(32),f=t("ee"),u=t(30),d=t(27),p=t(21),l=t(23),h=p.getConfiguration("ssl")===!1?"http":"https",m=window,v=m.document,w="addEventListener",g="attachEvent",y=m.XMLHttpRequest,x=y&&y.prototype,b=!d(m.location);NREUM.o={ST:setTimeout,SI:m.setImmediate,CT:clearTimeout,XHR:y,REQ:m.Request,EV:m.Event,PR:m.Promise,MO:m.MutationObserver};var E=""+location,R={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1212.min.js"},O=y&&x&&x[w]&&!/CriOS/.test(navigator.userAgent),T=e.exports={offset:a.getLastTimestamp(),now:a,origin:E,features:{},xhrWrappable:O,userAgent:u,disabled:b};if(!b){t(20),t(28),v[w]?(v[w]("DOMContentLoaded",i,l(!1)),m[w]("load",r,l(!1))):(v[g]("onreadystatechange",o),m[g]("onload",r)),s("mark",["firstbyte",a.getLastTimestamp()],null,"api");var P=0}},{}],"wrap-function":[function(t,e,n){function r(t,e){function n(e,n,r,c,f){function nrWrapper(){var i,a,u,p;try{a=this,i=d(arguments),u="function"==typeof r?r(i,a):r||{}}catch(l){o([l,"",[i,a,c],u],t)}s(n+"start",[i,a,c],u,f);try{return p=e.apply(a,i)}catch(h){throw s(n+"err",[i,a,h],u,f),h}finally{s(n+"end",[i,a,p],u,f)}}return a(e)?e:(n||(n=""),nrWrapper[p]=e,i(e,nrWrapper,t),nrWrapper)}function r(t,e,r,o,i){r||(r="");var s,c,f,u="-"===r.charAt(0);for(f=0;f<e.length;f++)c=e[f],s=t[c],a(s)||(t[c]=n(s,u?c+r:r,o,c,i))}function s(n,r,i,a){if(!h||e){var s=h;h=!0;try{t.emit(n,r,i,e,a)}catch(c){o([c,n,r,i],t)}h=s}}return t||(t=u),n.inPlace=r,n.flag=p,n}function o(t,e){e||(e=u);try{e.emit("internal-error",t)}catch(n){}}function i(t,e,n){if(Object.defineProperty&&Object.keys)try{var r=Object.keys(t);return r.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(i){o([i],n)}for(var a in t)l.call(t,a)&&(e[a]=t[a]);return e}function a(t){return!(t&&t instanceof Function&&t.apply&&!t[p])}function s(t,e){var n=e(t);return n[p]=t,i(t,n,u),n}function c(t,e,n){var r=t[e];t[e]=s(r,n)}function f(){for(var t=arguments.length,e=new Array(t),n=0;n<t;++n)e[n]=arguments[n];return e}var u=t("ee"),d=t(33),p="nr@original",l=Object.prototype.hasOwnProperty,h=!1;e.exports=r,e.exports.wrapFunction=s,e.exports.wrapInPlace=c,e.exports.argsToArray=f},{}]},{},["loader",2,17,5,3,4]);
  ;NREUM.loader_config={accountID:"804283",trustKey:"804283",agentID:"402703674",licenseKey:"cf99e8d2a3",applicationID:"402703674"}
  ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"cf99e8d2a3",
    // Modified this value from the generated script, to pass prod vs dev
    applicationID: window.location.hostname.includes('journals.plos.org') ? "402703674" : "402694889",
    sa:1}
</script>
<!-- End New Relic -->






<header>
  <div id="topslot" class="head-top">

<div class="center">
<div class="title">Advertisement</div>
<!-- DoubleClick Ad Zone -->
  <div class='advertisement' id='div-gpt-ad-1458247671871-0' style='width:728px; height:90px;'>
    <script type='text/javascript'>
      googletag.cmd.push(function() { googletag.display('div-gpt-ad-1458247671871-0'); });
    </script>
  </div>
</div>
  </div>

  <div id="user" class="nav" data-user-management-url="https://community.plos.org">
  </div>
  <div id="pagehdr">

    <nav class="nav-main">




<h1 class="logo">
  <a href="/plosone/.">PLOS ONE</a>
</h1>

<section class="top-bar-section"> 

<ul class="nav-elements">


    <li class="multi-col-parent menu-section-header has-dropdown" id="publish">
    Publish
      <div class="dropdown mega ">
        <ul class="multi-col" id="publish-dropdown-list">

  <li class="menu-section-header " id="submissions">
    <span class="menu-section-header-title">  Submissions </span>

    <ul class="menu-section "
        id="submissions-dropdown-list">
      <li>
    <a href="/plosone/s/getting-started" >Getting Started</a>
  </li>

      <li>
    <a href="/plosone/s/submission-guidelines" >Submission Guidelines</a>
  </li>

      <li>
    <a href="/plosone/s/figures" >Figures</a>
  </li>

      <li>
    <a href="/plosone/s/tables" >Tables</a>
  </li>

      <li>
    <a href="/plosone/s/supporting-information" >Supporting Information</a>
  </li>

      <li>
    <a href="/plosone/s/latex" >LaTeX</a>
  </li>

      <li>
    <a href="/plosone/s/what-we-publish" >What We Publish</a>
  </li>

      <li>
    <a href="/plosone/s/preprints" >Preprints</a>
  </li>

      <li>
    <a href="/plosone/s/revising-your-manuscript" >Revising Your Manuscript</a>
  </li>

      <li>
    <a href="/plosone/s/submit-now" >Submit Now</a>
  </li>

      <li>
    <a href="https://collections.plos.org/s/calls-for-papers" >Calls for Papers</a>
  </li>

    </ul>

  </li>


  <li class="menu-section-header " id="policies">
    <span class="menu-section-header-title">  Policies </span>

    <ul class="menu-section "
        id="policies-dropdown-list">
      <li>
    <a href="/plosone/s/best-practices-in-research-reporting" >Best Practices in Research Reporting</a>
  </li>

      <li>
    <a href="/plosone/s/human-subjects-research" >Human Subjects Research</a>
  </li>

      <li>
    <a href="/plosone/s/animal-research" >Animal Research</a>
  </li>

      <li>
    <a href="/plosone/s/competing-interests" >Competing Interests</a>
  </li>

      <li>
    <a href="/plosone/s/disclosure-of-funding-sources" >Disclosure of Funding Sources</a>
  </li>

      <li>
    <a href="/plosone/s/licenses-and-copyright" >Licenses and Copyright</a>
  </li>

      <li>
    <a href="/plosone/s/data-availability" >Data Availability</a>
  </li>

      <li>
    <a href="/plosone/s/complementary-research" >Complementary Research</a>
  </li>

      <li>
    <a href="/plosone/s/materials-software-and-code-sharing" >Materials, Software and Code Sharing</a>
  </li>

      <li>
    <a href="/plosone/s/ethical-publishing-practice" >Ethical Publishing Practice</a>
  </li>

      <li>
    <a href="/plosone/s/authorship" >Authorship</a>
  </li>

      <li>
    <a href="/plosone/s/corrections-expressions-of-concern-and-retractions" >Corrections, Expressions of Concern, and Retractions</a>
  </li>

    </ul>

  </li>


  <li class="menu-section-header " id="manuscript-review-and-publication">
    <span class="menu-section-header-title">  Manuscript Review and Publication </span>

    <ul class="menu-section "
        id="manuscript-review-and-publication-dropdown-list">
      <li>
    <a href="/plosone/s/criteria-for-publication" >Criteria for Publication</a>
  </li>

      <li>
    <a href="/plosone/s/editorial-and-peer-review-process" >Editorial and Peer Review Process</a>
  </li>

      <li>
    <a href="https://plos.org/resources/editor-center" >Editor Center</a>
  </li>

      <li>
    <a href="/plosone/s/resources-for-editors" >Resources for Editors</a>
  </li>

      <li>
    <a href="/plosone/s/reviewer-guidelines" >Guidelines for Reviewers</a>
  </li>

      <li>
    <a href="/plosone/s/accepted-manuscripts" >Accepted Manuscripts</a>
  </li>

      <li>
    <a href="/plosone/s/comments" >Comments</a>
  </li>

    </ul>

  </li>
        </ul>
          <div class="calloutcontainer">



  <h3 class="callout-headline">Submit Your Manuscript</h3>

  <div class="action-contain">
  <p class="callout-content">
  Discover a faster, simpler path to publishing in a high-quality journal. <em>PLOS ONE</em> promises fair, rigorous peer review,
  broad scope, and wide readership – a perfect fit for your research every time.
  </p>

  <p class="button-contain special">
    <a class="button button-default" href="/plosone/static/publish">
     Learn More
    </a>
    <a class="button-link" href="https://www.editorialmanager.com/pone/default.asp">
      Submit Now
    </a>
  </p>
  </div>  <!-- opens in siteMenuCalloutDescription -->


          </div>
      </div>
    </li>



  <li class="menu-section-header has-dropdown " id="about">
    <span class="menu-section-header-title">  About </span>

    <ul class="menu-section dropdown "
        id="about-dropdown-list">
      <li>
    <a href="/plosone/static/publish" >Why Publish with PLOS ONE</a>
  </li>

      <li>
    <a href="/plosone/s/journal-information" >Journal Information</a>
  </li>

      <li>
    <a href="/plosone/s/staff-editors" >Staff Editors</a>
  </li>

      <li>
    <a href="/plosone/static/editorial-board" >Editorial Board</a>
  </li>

      <li>
    <a href="/plosone/s/section-editors" >Section Editors</a>
  </li>

      <li>
    <a href="/plosone/s/advisory-groups" >Advisory Groups</a>
  </li>

      <li>
    <a href="/plosone/s/find-and-read-articles" >Find and Read Articles</a>
  </li>

      <li>
    <a href="/plosone/s/publishing-information" >Publishing Information</a>
  </li>

      <li>
    <a href="https://plos.org/publication-fees" >Publication Fees</a>
  </li>

      <li>
    <a href="https://plos.org/press-and-media" >Press and Media</a>
  </li>

      <li>
    <a href="/plosone/s/contact" >Contact</a>
  </li>

    </ul>

  </li>

  <li data-js-tooltip-hover="trigger" class="subject-area menu-section-header">
  Browse
  </li>

<script src="/resource/js/vendor/jquery.hoverIntent.js" type="text/javascript"></script>
<script src="/resource/js/components/menu_drop.js" type="text/javascript"></script>
<script src="/resource/js/components/hover_delay.js" type="text/javascript"></script>
      <li id="navsearch" class="head-search">


    <form name="searchForm" action="/plosone/search" method="get">
      <fieldset>
        <legend>Search</legend>
        <label for="search">Search</label>
        <div class="search-contain">
          <input id="search" type="text" name="q" placeholder="SEARCH" required/>
          <button id="headerSearchButton" type="submit" aria-label="Submit search">
            <i title="Submit search" class="search-icon"></i>
          </button>
        </div>
      </fieldset>
      <input type="hidden" name="filterJournals" value="PLoSONE"/>
    </form>

    <a id="advSearch"
       href="/plosone/search">
      advanced search
    </a>




<script src="/resource/js/components/placeholder_style.js" type="text/javascript"></script>
      </li>

      </ul>     
      </section>  
    </nav>
  </div>

</header>
<section id="taxonomyContainer">

<script src="/resource/js/taxonomy-browser.js" type="text/javascript"></script>
<div id="taxonomy-browser" class="areas" data-search-url="/plosone/browse">
  <div class="wrapper">
    <div class="taxonomy-header">
      Browse Subject Areas
      <div id="subjInfo">?</div>
      <div id="subjInfoText">
        <p>Click through the PLOS taxonomy to find articles in your field.</p>
        <p>For more information about PLOS Subject Areas, click
          <a href="https://github.com/PLOS/plos-thesaurus/blob/master/README.md" target="_blank" title="Link opens in new window">here</a>.
        </p>
      </div>
    </div>
    <div class="levels">
      <div class="levels-container cf">
        <div class="levels-position"></div>
      </div>
      <a href="#" class="prev"></a>
      <a href="#" class="next active"></a>
    </div>
  </div>
  <div class="taxonomy-browser-border-bottom"></div>
</div>
</section>
<main> <div class="set-grid">

<header class="title-block">



<script src="/resource/js/components/signposts.js" type="text/javascript"></script>

<ul id="almSignposts" class="signposts">
  <li id="loadingMetrics">
    <p>Loading metrics</p>
  </li>
</ul>

<script type="text/template" id="signpostsGeneralErrorTemplate">
  <li id="metricsError">Article metrics are unavailable at this time. Please try again later.</li>
</script>

<script type="text/template" id="signpostsNewArticleErrorTemplate">
  <li></li><li></li><li id="tooSoon">Article metrics are unavailable for recently published articles.</li>
</script>

<script type="text/template" id="signpostsTemplate">
    <li id="almSaves">
      <%= s.numberFormat(saveCount, 0) %>
      <div class="tools" data-js-tooltip-hover="trigger">
        <a class="metric-term" href="/plosone/article/metrics?id=10.1371/journal.pone.0087003#savedHeader">Save</a>
        <p class="saves-tip" data-js-tooltip-hover="target"><a href="/plosone/article/metrics?id=10.1371/journal.pone.0087003#savedHeader">Total Mendeley and Citeulike bookmarks.</a></p>
      </div>
    </li>

    <li id="almCitations">
      <%= s.numberFormat(citationCount, 0) %>
      <div class="tools" data-js-tooltip-hover="trigger">
        <a class="metric-term" href="/plosone/article/metrics?id=10.1371/journal.pone.0087003#citedHeader">Citation</a>
        <p class="citations-tip" data-js-tooltip-hover="target"><a href="/plosone/article/metrics?id=10.1371/journal.pone.0087003#citedHeader">Paper's citation count computed by Dimensions.</a></p>
      </div>
    </li>

    <li id="almViews">
      <%= s.numberFormat(viewCount, 0) %>
      <div class="tools" data-js-tooltip-hover="trigger">
        <a class="metric-term" href="/plosone/article/metrics?id=10.1371/journal.pone.0087003#viewedHeader">View</a>
        <p class="views-tip" data-js-tooltip-hover="target"><a href="/plosone/article/metrics?id=10.1371/journal.pone.0087003#viewedHeader">PLOS views and downloads.</a></p>
      </div>
    </li>

    <li id="almShares">
      <%= s.numberFormat(shareCount, 0) %>
      <div class="tools" data-js-tooltip-hover="trigger">
        <a class="metric-term" href="/plosone/article/metrics?id=10.1371/journal.pone.0087003#discussedHeader">Share</a>
        <p class="shares-tip" data-js-tooltip-hover="target"><a href="/plosone/article/metrics?id=10.1371/journal.pone.0087003#discussedHeader">Sum of Facebook, Twitter, Reddit and Wikipedia activity.</a></p>
      </div>
    </li>
</script>

    <div class="article-meta">

<div class="classifications">
  <p class="license-short" id="licenseShort">Open Access</p>
  <p class="peer-reviewed" id="peerReviewed">Peer-reviewed</p>

<div class="article-type" >
  <p class="type-article" id="artType">Research Article</p>
</div>


</div>


    </div>
    <div class="article-title-etc">



<div class="title-authors">
  <h1 id="artTitle"><?xml version="1.0" encoding="UTF-8"?>Regulation of <i>MYC</i> Expression and Differential JQ1 Sensitivity in Cancer Cells</h1>

<ul class="author-list clearfix"  data-js-tooltip="tooltip_container" id="author-list">



<li
  data-js-tooltip="tooltip_trigger"
  
>
   <a  data-author-id="0" class="author-name" >
Trent Fowler,</a>    <div id="author-meta-0" class="author-info" data-js-tooltip="tooltip_target">

  
  
  <p id="authAffiliations-0"><span class="type">Affiliation</span>
    Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, United States of America
  </p>

      <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose0"> &#x02A2F; </a>
    </div>
</li>

<li
  data-js-tooltip="tooltip_trigger"
  
>
   <a  data-author-id="1" class="author-name" >
Payel Ghatak,</a>    <div id="author-meta-1" class="author-info" data-js-tooltip="tooltip_target">

  
  
  <p id="authAffiliations-1"><span class="type">Affiliation</span>
    Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, United States of America
  </p>

      <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose1"> &#x02A2F; </a>
    </div>
</li>

<li
  data-js-tooltip="tooltip_trigger"
  
>
   <a  data-author-id="2" class="author-name" >
David H. Price,</a>    <div id="author-meta-2" class="author-info" data-js-tooltip="tooltip_target">

  
  
  <p id="authAffiliations-2"><span class="type">Affiliation</span>
    Biochemistry Department, University of Iowa, Iowa City, Iowa, United States of America
  </p>

      <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose2"> &#x02A2F; </a>
    </div>
</li>

<li
  data-js-tooltip="tooltip_trigger"
  
>
   <a  data-author-id="3" class="author-name" >
Ronald Conaway,</a>    <div id="author-meta-3" class="author-info" data-js-tooltip="tooltip_target">

  
  
  <p id="authAffiliations-3"><span class="type">Affiliation</span>
    Stowers Institute for Medical Research, Kansas City, Missouri, United States of America
  </p>

      <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose3"> &#x02A2F; </a>
    </div>
</li>

<li
  data-js-tooltip="tooltip_trigger"
  
>
   <a  data-author-id="4" class="author-name" >
Joan Conaway,</a>    <div id="author-meta-4" class="author-info" data-js-tooltip="tooltip_target">

  
  
  <p id="authAffiliations-4"><span class="type">Affiliation</span>
    Stowers Institute for Medical Research, Kansas City, Missouri, United States of America
  </p>

      <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose4"> &#x02A2F; </a>
    </div>
</li>

<li
  data-js-tooltip="tooltip_trigger"
  
>
   <a  data-author-id="5" class="author-name" >
Cheng-Ming Chiang,</a>    <div id="author-meta-5" class="author-info" data-js-tooltip="tooltip_target">

  
  
  <p id="authAffiliations-5"><span class="type">Affiliation</span>
    Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
  </p>

      <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose5"> &#x02A2F; </a>
    </div>
</li>

<li
  data-js-tooltip="tooltip_trigger"
  
>
   <a  data-author-id="6" class="author-name" >
James E. Bradner,</a>    <div id="author-meta-6" class="author-info" data-js-tooltip="tooltip_target">

  
  
  <p id="authAffiliations-6"><span class="type">Affiliation</span>
    Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America
  </p>

      <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose6"> &#x02A2F; </a>
    </div>
</li>

<li
  data-js-tooltip="tooltip_trigger"
  
>
   <a  data-author-id="7" class="author-name" >
Ali Shilatifard,</a>    <div id="author-meta-7" class="author-info" data-js-tooltip="tooltip_target">

  
  
  <p id="authAffiliations-7"><span class="type">Affiliation</span>
    Stowers Institute for Medical Research, Kansas City, Missouri, United States of America
  </p>

      <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose7"> &#x02A2F; </a>
    </div>
</li>

<li
  data-js-tooltip="tooltip_trigger"
  
>
   <a  data-author-id="8" class="author-name" >
Ananda L. Roy <span class="email">  </span></a>    <div id="author-meta-8" class="author-info" data-js-tooltip="tooltip_target">

  
  <p id="authCorresponding-8"> <span class="email">* E-mail:</span> <a href="mailto:ananda.roy@tufts.edu">ananda.roy@tufts.edu</a></p>
  <p id="authAffiliations-8"><span class="type">Affiliations</span>
    Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, United States of America, 
    Program in Genetics, Sackler School of Biomedical Science, Tufts University School of Medicine, Boston, Massachusetts, United States of America, 
    Program in Immunology, Sackler School of Biomedical Science, Tufts University School of Medicine, Boston, Massachusetts, United States of America
  </p>

      <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose8"> &#x02A2F; </a>
    </div>
</li>

</ul>
<script src="/resource/js/components/tooltip.js" type="text/javascript"></script>

</div>


<div id="floatTitleTop" data-js-floater="title_author" class="float-title">
  <div class="set-grid">
    <div class="float-title-inner">
      <h1><?xml version="1.0" encoding="UTF-8"?>Regulation of <i>MYC</i> Expression and Differential JQ1 Sensitivity in Cancer Cells</h1>

<ul id="floatAuthorList" data-js-floater="floated_authors">

  <li data-float-index="1">Trent Fowler,&nbsp;

  </li>
  <li data-float-index="2">Payel Ghatak,&nbsp;

  </li>
  <li data-float-index="3">David H. Price,&nbsp;

  </li>
  <li data-float-index="4">Ronald Conaway,&nbsp;

  </li>
  <li data-float-index="5">Joan Conaway,&nbsp;

  </li>
  <li data-float-index="6">Cheng-Ming Chiang,&nbsp;

  </li>
  <li data-float-index="7">James E. Bradner,&nbsp;

  </li>
  <li data-float-index="8">Ali Shilatifard,&nbsp;

  </li>
  <li data-float-index="9">Ananda L. Roy

  </li>

</ul>



    </div>
    <div class="logo-close" id="titleTopCloser">
      <img src="/resource/img/logo-plos.png" style="height: 2em" alt="PLOS" />
      <div class="close-floater" title="close">x</div>
    </div>
  </div>
</div>

      <ul class="date-doi">
        <li id="artPubDate">Published: January 23, 2014</li>
        <li id="artDoi">
<a   href="https://doi.org/10.1371/journal.pone.0087003">https://doi.org/10.1371/journal.pone.0087003</a>
        </li>
        <li class="flex-spacer"></li>
      </ul>

    </div>
  <div>

  </div>
</header>
  <section class="article-body">



<ul class="article-tabs">

          <li class="tab-title active" id="tabArticle">
            <a href="/plosone/article?id=10.1371/journal.pone.0087003" class="article-tab-1">Article</a>
        </li>


              <li class="tab-title " id="tabAuthors">
            <a href="/plosone/article/authors?id=10.1371/journal.pone.0087003" class="article-tab-2">Authors</a>
        </li>


          <li class="tab-title " id="tabMetrics">
            <a href="/plosone/article/metrics?id=10.1371/journal.pone.0087003" class="article-tab-3">Metrics</a>
        </li>


          <li class="tab-title " id="tabComments">
            <a href="/plosone/article/comments?id=10.1371/journal.pone.0087003" class="article-tab-4">Comments</a>
        </li>

  <li class="tab-title" id="tabRelated">
    <a class="article-tab-5" id="tabRelated-link">Media Coverage</a> 
    <script>$(document).ready(function() { $.getMediaLink("10.1371/journal.pone.0087003").then(function (url) { $("#tabRelated-link").attr("href", url) } ) })</script>
  </li>
</ul>

    <div class="article-container">


<div id="nav-article">
  <ul class="nav-secondary">

    <li class="nav-comments" id="nav-comments">
      <a href="article/comments?id=10.1371/journal.pone.0087003">Reader Comments</a>
    </li>

    <li id="nav-figures"><a href="#" data-doi="10.1371/journal.pone.0087003">Figures</a></li>
  </ul>
</div>
<script src="/resource/js/components/scroll.js" type="text/javascript"></script>
<script src="/resource/js/components/nav_builder.js" type="text/javascript"></script>
<script src="/resource/js/components/floating_nav.js" type="text/javascript"></script>

<div id="figure-lightbox-container"></div>

<script id="figure-lightbox-template" type="text/template">
  <div id="figure-lightbox" class="reveal-modal full" data-reveal aria-hidden="true"
       role="dialog">
    <div class="lb-header">
      <h1 id="lb-title"><%= articleTitle %></h1>

      <div id="lb-authors">
              <span>Trent Fowler</span>
              <span>Payel Ghatak</span>
          <a class="more-authors" href="/plosone/article/authors?id=10.1371/journal.pone.0087003">...</a>
          <span>Ananda L. Roy</span>
      </div>

      <div class="lb-close" title="close">&nbsp;</div>
    </div>
    <div class="img-container">
      <div class="loader"> <i class="fa-spinner"></i> </div>
      <img class="main-lightbox-image" src=""/>
      <aside id="figures-list">
        <% figureList.each(function (ix, figure) { %>
        <div class="change-img" data-doi="<%= figure.getAttribute('data-doi') %>">
          <img class="aside-figure" src="/plosone/article/figure/image?size=inline&id=<%= figure.getAttribute('data-doi') %>" />
        </div>
        <% }) %>
        <div class="dummy-figure">
        </div>
      </aside>
    </div>
    <div id="lightbox-footer">

      <div id="btns-container" class="lightbox-row <% if(figureList.length <= 1) { print('one-figure-only') } %>">
        <div class="fig-btns-container reset-zoom-wrapper left">
          <span class="fig-btn reset-zoom-btn">Reset zoom</span>
        </div>
        <div class="zoom-slider-container">
          <div class="range-slider-container">
            <span id="lb-zoom-min"></span>
            <div class="range-slider round" data-slider data-options="start: 20; end: 200; initial: 20;">
              <span class="range-slider-handle" role="slider" tabindex="0"></span>
              <span class="range-slider-active-segment"></span>
              <input type="hidden">
            </div>
            <span id="lb-zoom-max"></span>
          </div>
        </div>
        <% if(figureList.length > 1) { %>
        <div class="fig-btns-container">
          <span class="fig-btn all-fig-btn"><i class="icon icon-all"></i> All Figures</span>
          <span class="fig-btn next-fig-btn"><i class="icon icon-next"></i> Next</span>
          <span class="fig-btn prev-fig-btn"><i class="icon icon-prev"></i> Previous</span>
        </div>
        <% } %>
      </div>
      <div id="image-context">
      </div>
    </div>
  </div>
</script>

<script id="image-context-template" type="text/template">
  <div class="footer-text">
    <div id="figure-description-wrapper">
      <div id="view-more-wrapper" style="<% descriptionExpanded? print('display:none;') : '' %>">
        <span id="figure-title"><%= title %></span>
        <p id="figure-description">
          <%= description %>&nbsp;&nbsp;
        </p>
        <span id="view-more">show more<i class="icon-arrow-right"></i></span>

      </div>
      <div id="view-less-wrapper" style="<% descriptionExpanded? print('display:inline-block;') : '' %>" >
        <span id="figure-title"><%= title %></span>
        <p id="full-figure-description">
          <%= description %>&nbsp;&nbsp;
          <span id="view-less">show less<i class="icon-arrow-left"></i></span>
        </p>
      </div>
    </div>
  </div>
  <div id="show-context-container">
    <a class="btn show-context" href="<%= showInContext(strippedDoi) %>">Show in Context</a>
  </div>
  <div id="download-buttons">
    <h3>Download:</h3>
    <div class="item">
      <a href="/plosone/article/figure/image?size=original&download=&id=<%= doi %>" title="original image">
        <span class="download-btn">TIFF</span>
      </a>
      <span class="file-size"><%= fileSizes.original %></span>
    </div>
    <div class="item">
      <a href="/plosone/article/figure/image?size=large&download=&id=<%= doi %>" title="large image">
        <span class="download-btn">PNG</span>
      </a>
      <span class="file-size"><%= fileSizes.large %></span>
    </div>
    <div class="item">
      <a href="/plosone/article/figure/powerpoint?id=<%= doi %>" title="PowerPoint slide">
        <span class="download-btn">PPT</span>
      </a>
    </div>

  </div>
</script>
      <div class="article-content">




  <div class="amendment amendment-correction toc-section">
  <a data-toc="amendment-0" title="Correction" id="amendment-0" name="amendment-0"></a>

  <h2>Correction</h2>
    <div class="amendment-citation">
      <p>
          <span class="amendment-date">
            22 Apr 2015:
          </span>


Fowler&nbsp;T,
Ghatak&nbsp;P,
Price&nbsp;DH,
Conaway&nbsp;R,
Conaway&nbsp;J,

  et al.

  (2015)

    <?xml version="1.0" encoding="UTF-8"?>Correction: Regulation of <i>MYC</i> Expression and Differential JQ1 Sensitivity in Cancer Cells.

PLOS ONE  10(4): e0126328.

<a   href="https://doi.org/10.1371/journal.pone.0126328">https://doi.org/10.1371/journal.pone.0126328</a>


            <span class="link-separator"> </span>
            <a href="/plosone/article?id=10.1371/journal.pone.0126328" class="amendment-link">
              View 
  correction

            </a>
      </p>
    </div>
  </div>


<div id="figure-carousel-section">
  <h2>Figures</h2>

  <div id="figure-carousel">

    <div class="carousel-wrapper">
      <div class="slider">

          <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0087003.g001">

                <img src="/plosone/article/figure/image?size=inline&amp;id=10.1371/journal.pone.0087003.g001"
                     loading="lazy"
                     alt="Figure 1"
                />

            </div>

          <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0087003.g002">

                <img src="/plosone/article/figure/image?size=inline&amp;id=10.1371/journal.pone.0087003.g002"
                     loading="lazy"
                     alt="Figure 2"
                />

            </div>

          <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0087003.g003">

                <img src="/plosone/article/figure/image?size=inline&amp;id=10.1371/journal.pone.0087003.g003"
                     loading="lazy"
                     alt="Figure 3"
                />

            </div>

          <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0087003.g004">

                <img src="/plosone/article/figure/image?size=inline&amp;id=10.1371/journal.pone.0087003.g004"
                     loading="lazy"
                     alt="Figure 4"
                />

            </div>

          <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0087003.g005">

                <img src="/plosone/article/figure/image?size=inline&amp;id=10.1371/journal.pone.0087003.g005"
                     loading="lazy"
                     alt="Figure 5"
                />

            </div>

          <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0087003.g006">

                <img src="/plosone/article/figure/image?size=inline&amp;id=10.1371/journal.pone.0087003.g006"
                     loading="lazy"
                     alt="Figure 6"
                />

            </div>

          <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0087003.g007">

                <img src="/plosone/article/figure/image?size=inline&amp;id=10.1371/journal.pone.0087003.g007"
                     loading="lazy"
                     alt="Figure 7"
                />

            </div>
      </div>
    </div>

    <div class="carousel-control">
      <span class="button previous"></span>
      <span class="button next"></span>
    </div>
    <div class="carousel-page-buttons">

    </div>
  </div>
</div>
<script src="/resource/js/vendor/jquery.touchswipe.js" type="text/javascript"></script>
<script src="/resource/js/components/figure_carousel.js" type="text/javascript"></script>
<script src="/resource/js/vendor/jquery.dotdotdot.js" type="text/javascript"></script>


        <div class="article-text" id="artText">
          



<div xmlns:plos="http://plos.org" class="abstract toc-section abstract-type-"><a id="abstract0" name="abstract0" data-toc="abstract0" class="link-target" title="Abstract"></a><h2>Abstract</h2><div class="abstract-content"><a id="article1.front1.article-meta1.abstract1.p1" name="article1.front1.article-meta1.abstract1.p1" class="link-target"></a><p>High level MYC expression is associated with almost all human cancers. JQ1, a chemical compound that inhibits MYC expression is therapeutically effective in preclinical animal models in midline carcinoma, and Burkitt’s lymphoma (BL). Here we show that JQ1 does not inhibit MYC expression to a similar extent in all tumor cells. The BL cells showed a ∼90% decrease in MYC transcription upon treatment with JQ1, however, no corresponding reduction was seen in several non-BL cells. Molecularly, these differences appear due to requirements of Brd4, the most active version of the Positive Transcription Elongation Factor B (P-TEFb) within the Super Elongation Complex (SEC), and transcription factors such as Gdown1, and MED26 and also other unknown cell specific factors. Our study demonstrates that the regulation of high levels of MYC expression in different cancer cells is driven by unique regulatory mechanisms and that such exclusive regulatory signatures in each cancer cells could be employed for targeted therapeutics.</p>
</div></div>


<div xmlns:plos="http://plos.org" class="articleinfo"><p><strong>Citation: </strong>Fowler T, Ghatak P, Price DH, Conaway R, Conaway J, Chiang C-M, et al.  (2014) Regulation of <em>MYC</em> Expression and Differential JQ1 Sensitivity in Cancer Cells. PLoS ONE 9(1):
           e87003.
        
        https://doi.org/10.1371/journal.pone.0087003</p><p><strong>Editor: </strong>Arun Rishi, Wayne State University, United States of America</p><p><strong>Received: </strong>September 23, 2013; <strong>Accepted: </strong>December 16, 2013; <strong>Published: </strong> January 23, 2014</p><p><strong>Copyright: </strong> © 2014 Fowler et al. This is an open-access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>This work was supported in part by funds to C-M. C (NIH CA103867, CPRIT RP110471, and Welch Foundation I-1805), and A.L.R (American Heart Association, 12GRNT12180023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p><p><strong>Competing interests: </strong> J.E.B. has a minority equity allocation in Tensha Therapeutics. This does not alter the authors′ adherence to all the PLOS ONE policies on sharing data and materials.</p></div>





<div xmlns:plos="http://plos.org" id="section1" class="section toc-section"><a id="s1" name="s1" data-toc="s1" class="link-target" title="Introduction"></a><h2>Introduction</h2><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1" class="link-target"></a><p>Lymphomas are broadly classified into two categories: Hodgkin’s and non-Hodgkin’s lymphoma (NHL) <a href="#pone.0087003-Young1" class="ref-tip">[1]</a>. The two most common forms of aggressive NHL are diffuse large B cell lymphoma (DLBCL) and Burkitt’s lymphoma (BL) <a href="#pone.0087003-Young1" class="ref-tip">[1]</a>, <a href="#pone.0087003-Refaeli1" class="ref-tip">[2]</a>, <a href="#pone.0087003-Shaffer1" class="ref-tip">[3]</a>. Translocation of the proto-oncogene <em>MYC</em> into one of the immunoglobulin gene loci [<em>IG-MYC</em> translocation; mostly of the t(8;14)q24;q32 type] resulting in aberrant <em>MYC</em> expression is regarded as the dominant genetic event in the genesis of BL and about 10% of DLBCL <a href="#pone.0087003-Schrader1" class="ref-tip">[4]</a>. Besides translocation, <em>MYC</em> can undergo oncogenic deregulation via high-level gene amplification as well as mutations in cis-regulatory elements in several cancer types (e.g., myeloma, colon carcinoma and neuroblastoma) <a href="#pone.0087003-Ahmadiyeh1" class="ref-tip">[5]</a>, <a href="#pone.0087003-Selvanayagam1" class="ref-tip">[6]</a>. Moreover, while most BLs have deregulated c-<em>MYC</em> (henceforth referred to as <em>MYC</em>) expression as a consequence of an <em>IG-MYC</em> translocation, the majority of non-BLs do not carry <em>IG-MYC</em> translocations, but other genetic abnormalities leading to deregulated <em>MYC</em> expression. Though high expression is restricted to BLs, MYC target expression varies on a lower level across non-BL and intermediate lymphomas and constitutes a negative prognostic marker in these lymphomas.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2" class="link-target"></a><p>MYC dimerizes with MAX to bind its target sequence (E-box) and regulate gene expression. MYC not only activates transcription but also represses target gene expression either via direct biding (with Miz-1 transcription factor) or via regulation of micro-RNAs (miRs) <a href="#pone.0087003-Dang1" class="ref-tip">[7]</a>. However, the function of MYC is complicated as two recent studies show that MYC does not have a specific transcriptional signature but serves to amplify the output of existing transcriptional programs in a given cell rather than executing its own transcriptional program <a href="#pone.0087003-Lin1" class="ref-tip">[8]</a>, <a href="#pone.0087003-Nie1" class="ref-tip">[9]</a>.</p>
<a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3" class="link-target"></a><p><em>MYC</em> belongs to a class of genes called Primary Response Genes (PRGs) many of which harbor paused Pol II at the proximal promoter area that upon activation can quickly switch to an elongating Pol II and functional transcription <a href="#pone.0087003-Fowler1" class="ref-tip">[10]</a>. Signal dependent stimulation results in enhanced acetylation at histone 3 lysine 14 (H3K14Ac) and either of two H4 lysine pairs, H4K5/12 or H4K8/16, an event which appears crucial for the binding of bromodomain (BRD) proteins that recruit transcription factors necessary for transcription <a href="#pone.0087003-Muller1" class="ref-tip">[11]</a>, <a href="#pone.0087003-Dey1" class="ref-tip">[12]</a>. Recruitment of positive transcription elongation factor b (P-TEFb), and possibly the general initiation cofactor Mediator, plays an important role in Brd4-regulated transcription of many genes including <em>MYC</em>. Indeed, after recruitment by Brd4, P-TEFb phosphorylates the elongation factors DSIF (Spt4 and Spt5), negative elongation factor (NELF), and Pol II resulting in release of paused Pol II and subsequent elongation of transcription <a href="#pone.0087003-Fowler1" class="ref-tip">[10]</a>, <a href="#pone.0087003-Zhou1" class="ref-tip">[13]</a> and recently reviewed in <a href="#pone.0087003-Guo1" class="ref-tip">[14]</a>. Collectively, these and other results suggest that elongation of transcription is a critical regulatory point in orchestrating <em>MYC</em> regulation <a href="#pone.0087003-Fowler1" class="ref-tip">[10]</a>.</p>
<a id="article1.body1.sec1.p4" name="article1.body1.sec1.p4" class="link-target"></a><p>As many MYC-driven processes are required for homeostasis and growth, therapeutic strategies geared towards modulation of <em>MYC</em> expression rather than outright suppression seem attractive. The Mitsubishi Tanabe Pharma Corporation first described thienodiazepine analogs that potently inhibit chromatin binding of bromodomains related to the BET family <a href="#pone.0087003-Miyoshi1" class="ref-tip">[15]</a>. Subsequently, a closely related small molecule inhibitor, JQ1, has been found to be therapeutically effective in pre-clinical animal models <a href="#pone.0087003-Delmore1" class="ref-tip">[16]</a>, <a href="#pone.0087003-Filippakopoulos1" class="ref-tip">[17]</a>, <a href="#pone.0087003-Nicodeme1" class="ref-tip">[18]</a>. These and related small molecules competitively occupy the acetyl-binding pockets of BET bromodomains, resulting in release of BET proteins (in particular Brd4) from chromatin <a href="#pone.0087003-Mertz1" class="ref-tip">[19]</a>. Despite these promising demonstrations, JQ1 does not inhibit <em>MYC</em> expression to a similar extent in all tumor cells <a href="#pone.0087003-Mertz1" class="ref-tip">[19]</a>. Thus, it is important to understand why JQ1 is effective in only certain <em>MYC</em>-dependent cancers, which may ultimately determine clinical efficacy of this compound in patients.</p>
<a id="article1.body1.sec1.p5" name="article1.body1.sec1.p5" class="link-target"></a><p>We observed that although JQ1 treatment decreased Brd4 occupancy to a similar degree in the cell types tested, the ability of JQ1 to reduce <em>MYC</em> transcription between cells differed. In JQ1-sensitive cells, inhibition occurred at the level of nascent transcription affecting Pol II, “paused” Pol II-Ser5-P, “elongating” Pol II-Ser2-P, and P-TEFb occupancy. Furthermore, there is a difference in the occupancy of members of the Super Elongation Complex (SEC), and factors associated with RNA Polymerase II, at <em>MYC</em> promoter regions in the two cell types. Collectively, our data indicate high levels of <em>MYC</em> are maintained in different cancer cells via distinct mechanisms at the level of transcription elongation with different compliments of transcription factors and are therefore subjected to different JQ1 sensitivity.</p>
</div>

<div xmlns:plos="http://plos.org" id="section2" class="section toc-section"><a id="s2" name="s2" data-toc="s2" class="link-target" title="Materials and Methods"></a><h2>Materials and Methods</h2>
<div id="section1" class="section toc-section"><a id="s2a" name="s2a" class="link-target" title="Cell Culture"></a>
<h3>Cell Culture</h3>
<a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1" class="link-target"></a><p>The mature mouse B cell lymphoma BAL17 <a href="#pone.0087003-Kim1" class="ref-tip">[20]</a>, human BL lines Akata <a href="#pone.0087003-Takada1" class="ref-tip">[21]</a>, Raji <a href="#pone.0087003-Pulvertaft1" class="ref-tip">[22]</a>, and Ramos <a href="#pone.0087003-Clements1" class="ref-tip">[23]</a>, and human epithelial line HeLa-S3 <a href="#pone.0087003-Puck1" class="ref-tip">[24]</a> were cultured in RPMI media with HEPES (Invitrogen) supplemented with 100 U/ml Penicillin, 100 µg/ml Streptomycin, 1 mM Sodium Pyruvate, 0.5 mM 2-Mercaptoethanol solution (Invitrogen) and 10% Fetal Calf Sera (Atlanta Biologicals). RNA based assays used 1–2×10<sup>6</sup> cells and 2×10<sup>7</sup> cells were used for Chromatin Immunoprecipitation (ChIP). JQ1, solubilized in DMSO, was diluted into media at 1 µM and incubated with cells for 2 hours at 37°C. No effects on transcription were observed with DMSO controls (data not shown). Experiments shown in Figure S1 (<a href="#pone.0087003.s001">File S1</a>) involving BCR stimulation consisted of a 2 hr pre-treatment with 1 µM JQ1 followed by 30 minutes of exposure to antibody fragments specific for either human or mouse BCR (Jackson Immunoresearch).</p>
</div>

<div id="section2" class="section toc-section"><a id="s2b" name="s2b" class="link-target" title="RNA-Real Time PCR Analysis"></a>
<h3>RNA-Real Time PCR Analysis</h3>
<a id="article1.body1.sec2.sec2.p1" name="article1.body1.sec2.sec2.p1" class="link-target"></a><p>Performed as previously described <a href="#pone.0087003-Fowler2" class="ref-tip">[25]</a>. Ct values were averaged and the signal reported as the ratio of target over ActB mRNA via linear equations specific to each primer pair. Myc primers are listed in S3 (<a href="#pone.0087003.s001">File S1</a>) unless shown below.</p>
</div>

<div id="section3" class="section toc-section"><a id="s2c" name="s2c" class="link-target" title="mRNA Primers-mouse"></a>
<h3>mRNA Primers-mouse</h3>
<a id="article1.body1.sec2.sec3.p1" name="article1.body1.sec2.sec3.p1" class="link-target"></a><p>Myc Primers not listed in Figure S3 (<a href="#pone.0087003.s001">File S1</a>)</p>
<a id="article1.body1.sec2.sec3.p2" name="article1.body1.sec2.sec3.p2" class="link-target"></a><p>In1/Ex1 <span class="gene">5′-AGAGCTCCTCGAGCTGTTTG</span></p>
<a id="article1.body1.sec2.sec3.p3" name="article1.body1.sec2.sec3.p3" class="link-target"></a><p>    <span class="gene">5′-CGTCTACATTCAAGACGCAGA</span></p>
<a id="article1.body1.sec2.sec3.p4" name="article1.body1.sec2.sec3.p4" class="link-target"></a><p>ActB  <span class="gene">5′-AGGCATGGAGTCCTGTGGTATC</span></p>
<a id="article1.body1.sec2.sec3.p5" name="article1.body1.sec2.sec3.p5" class="link-target"></a><p>   <span class="gene">5′-AGCCACAGGTCCTAAGGCCAG</span>.</p>
<a id="article1.body1.sec2.sec3.p6" name="article1.body1.sec2.sec3.p6" class="link-target"></a><p>Fos  <span class="gene">5′-GGATTTGACTGGAGGTCTG</span></p>
<a id="article1.body1.sec2.sec3.p7" name="article1.body1.sec2.sec3.p7" class="link-target"></a><p>   <span class="gene">5′- TGGGCTCAGGGTCGTTGA</span></p>
</div>

<div id="section4" class="section toc-section"><a id="s2d" name="s2d" class="link-target" title="mRNA Primers Human"></a>
<h3>mRNA Primers Human</h3>
<a id="article1.body1.sec2.sec4.p1" name="article1.body1.sec2.sec4.p1" class="link-target"></a><p>Myc Primers not listed in Figure S3 (<a href="#pone.0087003.s001">File S1</a>)</p>
<a id="article1.body1.sec2.sec4.p2" name="article1.body1.sec2.sec4.p2" class="link-target"></a><p>In1/Ex2 <span class="gene">5′-GCACCAAGACCCCTTTAACTC</span></p>
<a id="article1.body1.sec2.sec4.p3" name="article1.body1.sec2.sec4.p3" class="link-target"></a><p>     5′-TCCTGTTGGTGAAGCTAACGEx2/In2 <span class="gene">5′-AGCGACTCTGGTAAGCGAAG</span></p>
<a id="article1.body1.sec2.sec4.p4" name="article1.body1.sec2.sec4.p4" class="link-target"></a><p>    <span class="gene">5′-GTGGCCCGTTAAATAAGCTG</span></p>
<a id="article1.body1.sec2.sec4.p5" name="article1.body1.sec2.sec4.p5" class="link-target"></a><p>ActB    <span class="gene">5′-CTCTTCCAGCCTTCCTTCCT</span></p>
<a id="article1.body1.sec2.sec4.p6" name="article1.body1.sec2.sec4.p6" class="link-target"></a><p>     <span class="gene">5′-AGCACTGTGTTGGCGTACAG</span></p>
<a id="article1.body1.sec2.sec4.p7" name="article1.body1.sec2.sec4.p7" class="link-target"></a><p>Fos    <span class="gene">5′-CTCCGGTGGTCACCTGTACT</span></p>
<a id="article1.body1.sec2.sec4.p8" name="article1.body1.sec2.sec4.p8" class="link-target"></a><p>     <span class="gene">5′-GTCAGAGGAAGGCTCATTGC</span></p>
</div>

<div id="section5" class="section toc-section"><a id="s2e" name="s2e" class="link-target" title="Western Blotting"></a>
<h3>Western Blotting</h3>
<a id="article1.body1.sec2.sec5.p1" name="article1.body1.sec2.sec5.p1" class="link-target"></a><p>Nuclear extracts from 2×10<sup>6</sup> cells were subjected to 10% (Myc) or 6% (Brd4) SDS-PAGE followed by Western blotting. Primary antibodies (rabbit anti-C-terminal Brd4-C IgG and rabbit anti-Brd4-S484/488-phos) <a href="#pone.0087003-Wu1" class="ref-tip">[26]</a>, <a href="#pone.0087003-Wu2" class="ref-tip">[27]</a>, rabbit anti-CREB IgG (Cell signaling) and secondary (goat anti-rabbit horseradish peroxidase-linked IgG, Invitrogen) antibodies at 1∶1500. Blots were visualized with the Novex ECL chemo-luminescent Substrate Regent Kit (Invitrogen) and densitometry performed with the ChemiDoc MP Imaging System (Biorad).</p>
</div>

<div id="section6" class="section toc-section"><a id="s2f" name="s2f" class="link-target" title="Strand-specific Detection"></a>
<h3>Strand-specific Detection</h3>
<a id="article1.body1.sec2.sec6.p1" name="article1.body1.sec2.sec6.p1" class="link-target"></a><p>380 ng of RNA with 1 µM final primer concentration were employed for each RT reaction using Invitrogen’s Cloned AMV First Strand synthesis kit. Strand-specific primers; for (+) strand the reverse primers corresponding to the TSS area (+17 for mouse and +11 for human) and for (−) strand forward primers corresponding to the end of the gene (+3948 for mouse and +4791 for human, sequences in Figure S3, in <a href="#pone.0087003.s001">File S1</a>). Standard real-time PCR amplification of the was employed with the indicated primers and their companions, shown in Figure S2 (<a href="#pone.0087003.s001">File S1</a>), and the resulting Ct values were converted to relative ng and normalized to the starting concentration of chromosomal RNA.</p>
</div>

<div id="section7" class="section toc-section"><a id="s2g" name="s2g" class="link-target" title="Chromatin Immunoprecipitation (ChIP)"></a>
<h3>Chromatin Immunoprecipitation (ChIP)</h3>
<a id="article1.body1.sec2.sec7.p1" name="article1.body1.sec2.sec7.p1" class="link-target"></a><p>A standard ChIP assay was performed and has been previously described <a href="#pone.0087003-Fowler2" class="ref-tip">[25]</a>. PCR primers and scheme are shown in Figure S3, in <a href="#pone.0087003.s001">File S1</a>. Ct values were averaged and the signal represented as % of input DNA via linear equations specific to each primer pair.</p>
</div>

<div id="section8" class="section toc-section"><a id="s2h" name="s2h" class="link-target" title="ChIP Antibodies"></a>
<h3>ChIP Antibodies</h3>
<a id="article1.body1.sec2.sec8.p1" name="article1.body1.sec2.sec8.p1" class="link-target"></a><p>Rabbit polyclonal anti-mouse RNA Pol II (N-20, sc-899, Santa Cruz), RNA Pol II-Ser5P mouse monoclonal (sc-47701, Santa Cruz), RNA Pol II-Ser2P H5 mouse ascites (Covance), H3K36me3 Rabbit polyclonal (ab9050, Abcam), anti-Cyclin T rabbit polyclonal (H-245, sc-10750, Santa Cruz), rabbit anti-C-terminal BRD4 IgG <a href="#pone.0087003-Wu2" class="ref-tip">[27]</a>, MED26 mouse anti-MED26/CRSP7 (Ab50619, Abcam), Gdown1 sheep anti-Gdown1 IgG <a href="#pone.0087003-Cheng1" class="ref-tip">[28]</a>, anti-AFF4 antibody <a href="#pone.0087003-Lin2" class="ref-tip">[29]</a> and anti-ELL2 antibody <a href="#pone.0087003-Lin2" class="ref-tip">[29]</a>.</p>
</div>

<div id="section9" class="section toc-section"><a id="s2i" name="s2i" class="link-target" title="Sequencing Analysis"></a>
<h3>Sequencing Analysis</h3>
<a id="article1.body1.sec2.sec9.p1" name="article1.body1.sec2.sec9.p1" class="link-target"></a><p>Figure S2 (<a href="#pone.0087003.s001">File S1</a>) shows sequencing data derived from University of California Santa Cruz Genome Browser (UCSC GB) tracks “wgEncodeUtaChIPseqBaseOverlapSignalHelas3Pol2” (HeLa S3) and GEO data set GSM920942 (Raji), mapped to human genome build hg18. The University of California Santa Cruz Genome Web Browser setting normalized to the highest peak at the TSS.</p>
</div>
</div>

<div xmlns:plos="http://plos.org" id="section3" class="section toc-section"><a id="s3" name="s3" data-toc="s3" class="link-target" title="Results"></a><h2>Results</h2>
<div id="section1" class="section toc-section"><a id="s3a" name="s3a" class="link-target" title="Differential JQ1 Sensitivity"></a>
<h3>Differential JQ1 Sensitivity</h3>
<a id="article1.body1.sec3.sec1.p1" name="article1.body1.sec3.sec1.p1" class="link-target"></a><p>We performed dose- and time-dependent testing of Brd4 inhibition with JQ1 and noted the effect on <em>MYC</em> transcription in a variety of cells including HeLa-S3 cells, whose MYC expression was reported <a href="#pone.0087003-Mertz1" class="ref-tip">[19]</a> to be resistant to JQ1 treatment. Shown in <a href="#pone-0087003-g001">Fig. 1A</a>, tested cell lines express <em>MYC</em> at high levels, comparable to levels detected at the peak of primary naïve resting B cell induction (data not shown). Steady state mRNA levels of <em>MYC</em> in a non-BL murine B cell lymphoma line (BAL17) that over expresses <em>MYC</em> at levels similar to the BL cells and HeLa cells showed no significant sensitivity to JQ1 (<a href="#pone-0087003-g001">Fig. 1A</a>). Both HeLa and BAL17 cells continued this resistance at concentrations up to 5 µM (data not shown), while <em>MYC</em> RNA in BL cells was uniformly decreased by ∼90% when treated with 1 µM of JQ1 for a period of two hours (<a href="#pone-0087003-g001">Fig. 1A</a>). BL cells are reported to express 2- to 5-fold more <em>MYC</em>-specific RNA than B-cell lines without a translocation <a href="#pone.0087003-Maguire1" class="ref-tip">[30]</a>. Although Western blotting d indicate the Raji BL line expresses more MYC protein, consistent with the mRNA data (<a href="#pone-0087003-g001">Fig. 1A</a>), JQ1 treatment decreased MYC protein expression in Raji but not HeLa and BAL17 (data not shown). Together these results demonstrated that JQ1 resistance occurred in both non-lymphoma and lymphoma cell lines representing both murine and human species.</p>
<a class="link-target" id="pone-0087003-g001" name="pone-0087003-g001"></a><div class="figure" data-doi="10.1371/journal.pone.0087003.g001"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&amp;id=10.1371/journal.pone.0087003.g001" data-doi="10.1371/journal.pone.0087003" data-uri="10.1371/journal.pone.0087003.g001"><img src="article/figure/image?size=inline&amp;id=10.1371/journal.pone.0087003.g001" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download">
          Download:
          <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0087003.g001"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&amp;size=large&amp;id=10.1371/journal.pone.0087003.g001"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&amp;size=original&amp;id=10.1371/journal.pone.0087003.g001"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Figure 1. </span> Effects of JQ1 on <em>MYC</em> expression.</div><p class="caption_target"><a id="article1.body1.sec3.sec1.fig1.caption1.p1" name="article1.body1.sec3.sec1.fig1.caption1.p1" class="link-target"></a><p>BAL17 (Murine B cell), Human HeLa, and Human BL Raji cells and either untreated or treated with 1 µM of JQ1 for 2 hours. (A) mRNA analysis was performed in triplicate, reported relative to ActB mRNA expression and is shown as the average and standard deviation of three experiments. (B) Detection of primary transcription by PCR amplification using primers across internal exon/intron borders of <em>MYC</em> was performed three times and reported relative to ActB mRNA expression. (C) Strand-specific transcription was detected by strand specific reverse transcription amplification as detailed in Material and Methods followed by standard PCR methods. These experiments were performed twice.</p>
</p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0087003.g001">
              https://doi.org/10.1371/journal.pone.0087003.g001</a></p></div><a id="article1.body1.sec3.sec1.p2" name="article1.body1.sec3.sec1.p2" class="link-target"></a><p>Because mRNA production may not necessarily correlate with primary transcript production <a href="#pone.0087003-Fowler2" class="ref-tip">[25]</a>, <a href="#pone.0087003-Bhatt1" class="ref-tip">[31]</a>, we tested the effect of JQ1 on primary transcription. Analysis of primary transcript, performed with primers against the exon/intron borders of <em>MYC</em> (schematically represented in Supplemental <a href="#pone-0087003-g003">Fig. 3</a> and/or listed in Materials and Methods), showed that primary transcription sensitivity to JQ1 was parallel to that of mRNA (<a href="#pone-0087003-g001">Fig. 1B</a>). Thus, long, and presumably full-length, primary transcripts were either resistant (BAL17 or HeLa) or sensitive (Raji) to JQ1. Therefore, the difference in JQ1 responses correlated with primary transcription and did not occur at the level of post-transcriptional modification, such as splicing and mRNA or protein stability.</p>
<a id="article1.body1.sec3.sec1.p3" name="article1.body1.sec3.sec1.p3" class="link-target"></a><p>Divergent transcription is common of many promoters in organisms and plays an important role in gene regulation <a href="#pone.0087003-Seila1" class="ref-tip">[32]</a>. Indeed, antisense transcription from the <em>MYC</em> locus has been observed in several cell lines <a href="#pone.0087003-Klemsz1" class="ref-tip">[33]</a>. Because we only measured total steady state RNA (<a href="#pone-0087003-g001">Fig. 1A</a>), whether differential JQ1 sensitivity reflects differences in possible transcription originating from the 3′ end was tested. Although antisense transcription in both BAL17 and HeLa cells was small in comparison to sense transcription, it was largely unaffected by JQ1 (<a href="#pone-0087003-g001">Fig. 1C</a>, left and middle panels). The wide difference in levels of sense and antisense transcripts observed amongst different cell lines is currently unexplained but might reflect a combination of transcriptional and post-transcriptional effects. Regardless, like sense transcription, antisense transcription originating from the <em>MYC</em> locus in Raji cells was inhibited by JQ1 (<a href="#pone-0087003-g001">Fig. 1C, right panel</a>). Therefore, although more antisense transcription was noted in Raji cells, the difference in JQ1 sensitivity was not likely due to differences in antisense transcripts.</p>
</div>

<div id="section2" class="section toc-section"><a id="s3b" name="s3b" class="link-target" title="JQ1 Leads to Decreased Brd4 Occupancy in Resistant and Sensitive Cells"></a>
<h3>JQ1 Leads to Decreased Brd4 Occupancy in Resistant and Sensitive Cells</h3>
<a id="article1.body1.sec3.sec2.p1" name="article1.body1.sec3.sec2.p1" class="link-target"></a><p>We observed that Brd4 recruitment was reduced by JQ1 in both cell types–therefore, the difference in JQ1 sensitivity between different cells was not due to permeability. We also observed that Brd4 recruitment to the transcription start site (TSS) was roughly 2.5 fold more in Raji (+11) cells compared to BAL17 (+17) (<a href="#pone-0087003-g002">Fig. 2A</a>). HeLa exhibited Brd4 recruitment and JQ1 sensitivity similar to BAL17 (data not shown). Moreover, a significant amount of Brd4 occupancy was noted across the body of <em>MYC</em> in all the cells tested, though there was a higher level of coding region occupancy in BAL17 cells. Though commonly associated with 5′-end enhancers and promoters, Brd4 has been shown to occupy the coding region of PRGs such as c-<em>fos</em> and <em>MYC</em> <a href="#pone.0087003-Wu1" class="ref-tip">[26]</a>.</p>
<a class="link-target" id="pone-0087003-g002" name="pone-0087003-g002"></a><div class="figure" data-doi="10.1371/journal.pone.0087003.g002"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&amp;id=10.1371/journal.pone.0087003.g002" data-doi="10.1371/journal.pone.0087003" data-uri="10.1371/journal.pone.0087003.g002"><img src="article/figure/image?size=inline&amp;id=10.1371/journal.pone.0087003.g002" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download">
          Download:
          <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0087003.g002"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&amp;size=large&amp;id=10.1371/journal.pone.0087003.g002"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&amp;size=original&amp;id=10.1371/journal.pone.0087003.g002"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Figure 2. </span> Brd4 occupancy and expression in different cells.</div><p class="caption_target"><a id="article1.body1.sec3.sec2.fig1.caption1.p1" name="article1.body1.sec3.sec2.fig1.caption1.p1" class="link-target"></a><p>Cells were either untreated or treated with 1 µM of JQ1 for 2 hours. (A) Chromatin Immunoprecipitation (ChIP) across <em>MYC</em> with anti-C-terminal Brd4 antibody. Each experiment was performed twice, analyzed in triplicate via real-time PCR and reported as the mean and standard deviation of the two experiments. A representation of the promoter area of <em>MYC</em> is provided for orientation. (B) Western blotting to detect (far left) Brd4 (∼180 KD) and (middle) Brd4-S484/488-phos (P-Brd4, ∼220 KD) was performed three times. A non-specific band detected with phopsho-Brd4 antibody is denoted with an asterisk. Typical results are shown with densitometry analysis relative to CREB expression, which is used as a normalization control (far right).</p>
</p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0087003.g002">
              https://doi.org/10.1371/journal.pone.0087003.g002</a></p></div><a id="article1.body1.sec3.sec2.p2" name="article1.body1.sec3.sec2.p2" class="link-target"></a><p>Promoter recruitment of Brd4 requires phosphorylation at S484 and S488 and deletion of this region results in decreased CycT and Pol II occupancy and transcription <a href="#pone.0087003-Wu1" class="ref-tip">[26]</a>. Consistent with the ChIP assay, Western blotting showed a higher level of total Brd4 in Raji nuclear extracts compared to HeLa and BAL17, although Brd4-S484P/S488P in Raji cells was slightly less compared to BAL17 and HeLa (<a href="#pone-0087003-g002">Fig. 2B</a>). Interestingly, the P-BRD4 band in HeLa cells migrated faster than either the Raji or BAL17 P-Brd4 band, perhaps reflecting a slight difference in the extent or site of phosphorylation. However, the difference in phosphorylated Brd4 (the active form) between different cells might not explain the differences in JQ1 sensitivity.</p>
<a id="article1.body1.sec3.sec2.p3" name="article1.body1.sec3.sec2.p3" class="link-target"></a><p>Brd4 interacts with factors that either recruit Pol II to the site of transcription or drive the transcriptional complex from pausing to the elongation mode (reviewed in <a href="#pone.0087003-Fowler1" class="ref-tip">[10]</a>). Additionally, a reduction of functional Brd4 resulting in greatly reduced Pol II occupancy was shown to involve a loss of P-TEFb <a href="#pone.0087003-Wu1" class="ref-tip">[26]</a>. Although the level and pattern of P-TEFb occupancy in both untreated JQ1 sensitive and resistant cell types were similar, JQ1 treatment/Brd4 inhibition decreased P-TEFb occupancy only in Raji cells (<a href="#pone-0087003-g003">Fig. 3</a>). These results indicated levels of BRD4 dependence for maintaining P-TEFb occupancy vary in different cell lines (<a href="#pone-0087003-g003">Fig. 3</a>).</p>
<a class="link-target" id="pone-0087003-g003" name="pone-0087003-g003"></a><div class="figure" data-doi="10.1371/journal.pone.0087003.g003"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&amp;id=10.1371/journal.pone.0087003.g003" data-doi="10.1371/journal.pone.0087003" data-uri="10.1371/journal.pone.0087003.g003"><img src="article/figure/image?size=inline&amp;id=10.1371/journal.pone.0087003.g003" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download">
          Download:
          <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0087003.g003"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&amp;size=large&amp;id=10.1371/journal.pone.0087003.g003"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&amp;size=original&amp;id=10.1371/journal.pone.0087003.g003"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Figure 3. </span> Effects of JQ1 on P-TEFb occupancy.</div><p class="caption_target"><a id="article1.body1.sec3.sec2.fig2.caption1.p1" name="article1.body1.sec3.sec2.fig2.caption1.p1" class="link-target"></a><p>BAL17 and Raji cells were either untreated or treated with 1 µM of JQ1 for 2 hours. Recruitment of P-TEFb was detected by ChIP assays. Each experiment was analyzed in triplicate via real-time PCR, performed twice, and is reported as the mean and standard deviation of the two experiments.</p>
</p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0087003.g003">
              https://doi.org/10.1371/journal.pone.0087003.g003</a></p></div></div>

<div id="section3" class="section toc-section"><a id="s3c" name="s3c" class="link-target" title="RNA Pol II Recruitment"></a>
<h3>RNA Pol II Recruitment</h3>
<a id="article1.body1.sec3.sec3.p1" name="article1.body1.sec3.sec3.p1" class="link-target"></a><p>We next determined if the difference in JQ1 selectivity was due to a difference in general transcription apparatus recruitment, represented by RNA Polymerase II (Pol II). While total Pol II was greatly decreased across the body of <em>MYC</em> in Raji cells upon JQ1 treatment, it was not altered in the JQ1 resistant BAL17 line (<a href="#pone-0087003-g004">Fig. 4A</a>). Both cell types showed Pol II occupancy at the P<sub>0</sub> promoter, which has been shown to correlate with a very high level of transcription <a href="#pone.0087003-Lee1" class="ref-tip">[34]</a>. Many actively transcribed genes (including <em>MYC</em>) exhibit paused Pol II at their proximal promoters <a href="#pone.0087003-Gilchrist1" class="ref-tip">[35]</a>. Consistent with this notion, we observed a high level of promoter-associated Pol II in both cell types, although two-fold more Pol II was noted at the proximal promoter (roughly corresponding to the P<sub>0</sub> promoter region) in BAL17 (−354) compared to Raji (−279). Interestingly, as noted with Brd4 and P-TEFb (<a href="#pone-0087003-g003">Figs. 3</a> and <a href="#pone-0087003-g004">4</a>), total Pol II was reduced at a site immediately downstream (+0.6 kb) of the TSS and sharply increased afterward (<a href="#pone-0087003-g004">Fig. 4A</a>).</p>
<a class="link-target" id="pone-0087003-g004" name="pone-0087003-g004"></a><div class="figure" data-doi="10.1371/journal.pone.0087003.g004"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&amp;id=10.1371/journal.pone.0087003.g004" data-doi="10.1371/journal.pone.0087003" data-uri="10.1371/journal.pone.0087003.g004"><img src="article/figure/image?size=inline&amp;id=10.1371/journal.pone.0087003.g004" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download">
          Download:
          <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0087003.g004"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&amp;size=large&amp;id=10.1371/journal.pone.0087003.g004"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&amp;size=original&amp;id=10.1371/journal.pone.0087003.g004"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Figure 4. </span> RNA Polymerase II occupancy in the absence and presence of JQ1.</div><p class="caption_target"><a id="article1.body1.sec3.sec3.fig1.caption1.p1" name="article1.body1.sec3.sec3.fig1.caption1.p1" class="link-target"></a><p>Cells were either untreated or treated with 1 µM of JQ1 for 2 hours. (A) Pol II was detected by antibody against the N-terminal of Pol II (B) Pol II Serine 5-P (C) Pol II Serine 2-P. Chromatin ChIP assays were performed in duplicate. Each experiment was analyzed in triplicate via real-time PCR, performed twice, and is reported as the mean and standard deviation of the two experiments.</p>
</p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0087003.g004">
              https://doi.org/10.1371/journal.pone.0087003.g004</a></p></div><a id="article1.body1.sec3.sec3.p2" name="article1.body1.sec3.sec3.p2" class="link-target"></a><p>Because phosphorylation of the carboxy-terminal domain (CTD) of RNA Pol II is associated with regulation of transcription initiation and elongation at many promoters <a href="#pone.0087003-Buratowski1" class="ref-tip">[36]</a>, <a href="#pone.0087003-Buratowski2" class="ref-tip">[37]</a>, we analyzed these events in the two cell types in the absence and presence of JQ1. While RNA Pol II phospho-Ser5 (Pol II S5P) levels in BAL17 cells remained stable after JQ1 treatment, Pol II S5P levels in Raji cells were sensitive to JQ1 (<a href="#pone-0087003-g004">Fig. 4B</a>). However, surprisingly, Pol II S5P levels were refractory at P<sub>0</sub> and TSS sites (<a href="#pone-0087003-g004">Fig. 4B, right panel</a>) but sensitive in the latter half of the gene with a small change starting downstream of the <em>MYC</em> P3 promoter (+2244) and becoming increasingly sensitive further down the body of the gene. Whether the substantial amount of Pol II-Ser5P 3′ occupancy shown here is directly due to 3′ Brd4 occupancy or an overabundance of transcription complexes “backing up” resulting in reduced elongation and subsequent pausing at the 3′ terminus is unknown.</p>
<a id="article1.body1.sec3.sec3.p3" name="article1.body1.sec3.sec3.p3" class="link-target"></a><p>While Ser5 phosphorylation is associated with a competent but paused Pol II, Ser2 phosphorylation of the Pol II CTD (Pol II S2P) represents elongating Pol II <a href="#pone.0087003-Buratowski2" class="ref-tip">[37]</a>. In the absence of JQ1, Pol II S2P occupancy in both cell types occurred across the body of the gene with peaks at the promoter regions, and the 3′ end. Surprisingly, while promoter- and TSS-associated Pol II S2P levels in Raji cells were sensitive to JQ1, downstream regions past P<sub>3</sub> exhibited no JQ1 sensitivity until past the 3′ UTR (+5472) (<a href="#pone-0087003-g004">Fig. 4C</a>), suggesting that the majority of fully elongating RNA polymerase II in these JQ1 sensitive cells was refractory to JQ1. We also observed a JQ1-dependent increase in Pol II-Ser2P in the BAL17 line and while this increase was slight at the promoter and TSS regions, it was very clear at the 3′ terminus.</p>
</div>

<div id="section4" class="section toc-section"><a id="s3d" name="s3d" class="link-target" title="Differences in H3K36me3"></a>
<h3>Differences in H3K36me3</h3>
<a id="article1.body1.sec3.sec4.p1" name="article1.body1.sec3.sec4.p1" class="link-target"></a><p>One possible way to delineate between upstream and downstream effects on Pol II-Ser2 occupancy is to determine the pattern of tri-methylation of the histone 3 residue lysine 36, H3K36me3, which is indicative of a recently passing elongating transcription complex <a href="#pone.0087003-Buratowski2" class="ref-tip">[37]</a>. In BAL17 cells, JQ1 treatment enhanced the H3K36me3 signals across the gene (<a href="#pone-0087003-g005">Fig. 5</a>). But in Raji cells, JQ1 treatment decreased H3K36me3 from P<sub>0</sub> through TSS until the P<sub>3</sub> region. However, beyond P3, the H3K36me3 became refractory to JQ1 (<a href="#pone-0087003-g005">Fig. 5</a>) as observed with Pol II S2P (<a href="#pone-0087003-g004">Fig. 4C</a>), suggesting that once RNA Pol II was in elongation mode, it was insensitive to JQ1. Together, our data showed that <em>MYC</em> harbored transcription complexes with variable Brd4 dependency in different cell types and that Brd4 inhibition resulted in a differential response at the level of transition from pausing to elongation.</p>
<a class="link-target" id="pone-0087003-g005" name="pone-0087003-g005"></a><div class="figure" data-doi="10.1371/journal.pone.0087003.g005"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&amp;id=10.1371/journal.pone.0087003.g005" data-doi="10.1371/journal.pone.0087003" data-uri="10.1371/journal.pone.0087003.g005"><img src="article/figure/image?size=inline&amp;id=10.1371/journal.pone.0087003.g005" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download">
          Download:
          <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0087003.g005"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&amp;size=large&amp;id=10.1371/journal.pone.0087003.g005"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&amp;size=original&amp;id=10.1371/journal.pone.0087003.g005"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Figure 5. </span> Effects of JQ1 on H3K36me3 status.</div><p class="caption_target"><a id="article1.body1.sec3.sec4.fig1.caption1.p1" name="article1.body1.sec3.sec4.fig1.caption1.p1" class="link-target"></a><p>Cells were either untreated or treated with 1 µM of JQ1 for 2 hours. ChIP assays were performed in duplicate. Each experiment was analyzed in triplicate via real-time PCR, performed twice, and is reported as the mean and standard deviation of the two experiments.</p>
</p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0087003.g005">
              https://doi.org/10.1371/journal.pone.0087003.g005</a></p></div></div>

<div id="section5" class="section toc-section"><a id="s3e" name="s3e" class="link-target" title="Accessory Transcription Elongation Factors"></a>
<h3>Accessory Transcription Elongation Factors</h3>
<a id="article1.body1.sec3.sec5.p1" name="article1.body1.sec3.sec5.p1" class="link-target"></a><p>P-TEFb frequently functions as a subunit of Super Elongation Complexes (SEC), consisting of P-TEFb and a mixture of one of three ELL family members, one of two EAF family members, one of two AF4 family members (AFF1 and AFF4), and either ENL or AF9 <a href="#pone.0087003-Lin2" class="ref-tip">[29]</a>, <a href="#pone.0087003-Biswas1" class="ref-tip">[38]</a>. As the SEC family of Pol II elongation factors are reported to contain the most catalytically active versions of P-TEFb active in high-level transcription and to regulate a checkpoint stage of transcription associated with elongation <a href="#pone.0087003-Lin2" class="ref-tip">[29]</a>, <a href="#pone.0087003-Luo1" class="ref-tip">[39]</a>, <a href="#pone.0087003-Luo2" class="ref-tip">[40]</a>, we looked at SEC recruitment at <em>MYC</em> in different cell types. AFF4 is reported to serve as a central binding platform for elongation factors in many SEC formations and to target <em>MYC</em> and regulate its expression in cancer cells <a href="#pone.0087003-Luo1" class="ref-tip">[39]</a>. The level of AFF4 occupancy in BAL17 cells was low and refractory to JQ1 (<a href="#pone-0087003-g006">Fig. 6A</a>, top panel) but increased in the presence of JQ1. In contrast, AFF4 recruitment in Raji cells was much greater and sensitive to JQ1. Although the AFF4 promoter occupancy in Raji cells, particularly around 2244 site, was variable in the absence of JQ1, it was significantly decreased in the presence of JQ1. Moreover, consistent with the Pol II S2P and H3K36me3 results, JQ1 sensitivity was lost past the P<sub>3</sub> promoter region (+2244), once again suggesting that the elongating transcription complex was refractory to JQ1 (<a href="#pone-0087003-g006">Fig. 6A</a>, bottom panel).</p>
<a class="link-target" id="pone-0087003-g006" name="pone-0087003-g006"></a><div class="figure" data-doi="10.1371/journal.pone.0087003.g006"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&amp;id=10.1371/journal.pone.0087003.g006" data-doi="10.1371/journal.pone.0087003" data-uri="10.1371/journal.pone.0087003.g006"><img src="article/figure/image?size=inline&amp;id=10.1371/journal.pone.0087003.g006" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download">
          Download:
          <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0087003.g006"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&amp;size=large&amp;id=10.1371/journal.pone.0087003.g006"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&amp;size=original&amp;id=10.1371/journal.pone.0087003.g006"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Figure 6. </span> Occupancy of elongation factors at the <em>MYC</em> locus.</div><p class="caption_target"><a id="article1.body1.sec3.sec5.fig1.caption1.p1" name="article1.body1.sec3.sec5.fig1.caption1.p1" class="link-target"></a><p>Cells were either untreated or treated with 1 µM of JQ1 for 2 hours. (A) AFF4 was detected by ChIP across the length of the <em>MYC</em> gene in both BAL17 and Raji cells. (B) Detection of AFF4, ELL2 and MED26 in the promoter regions of untreated human HeLa and Raji cells. ChIP assays were performed in duplicate. Each experiment was analyzed in triplicate via real-time PCR, performed twice, and is reported as the mean and standard deviation of the two experiments.</p>
</p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0087003.g006">
              https://doi.org/10.1371/journal.pone.0087003.g006</a></p></div><a id="article1.body1.sec3.sec5.p2" name="article1.body1.sec3.sec5.p2" class="link-target"></a><p>We subsequently looked at occupancy of another SEC component, ELL2, which has been reported to play a role in the transition from paused Pol II to elongation <a href="#pone.0087003-Luo2" class="ref-tip">[40]</a>. We also tested occupancy of the Mediator component (MED26) as well as Gdown1. Though first linked to initiation, a role for Mediator in recruiting Pol II transcription elongation factors and phosphorylation of the Pol II CTD regulating Pol II pausing and elongation has emerged <a href="#pone.0087003-Takahashi1" class="ref-tip">[41]</a>. The Mediator complex most strongly associated with Pol II includes MED26, which has been shown to increase activation of transcription in vitro to a greater degree than other forms of the Mediator complex and play a key role in SEC recruitment and MYC transcription <a href="#pone.0087003-Takahashi1" class="ref-tip">[41]</a>. Gdown1 is a Pol II binding protein shown to be necessary for a Mediator-dependent response to activation of transcription <a href="#pone.0087003-Hu1" class="ref-tip">[42]</a>. More appropriate to this study, Gdown1 has recently been shown to increase the stability of paused Pol II and regulate P-TEFb activity <a href="#pone.0087003-Cheng1" class="ref-tip">[28]</a>.</p>
<a id="article1.body1.sec3.sec5.p3" name="article1.body1.sec3.sec5.p3" class="link-target"></a><p>Because the available antibodies against ELL2, Med26 and Gdown1 were species (human) specific, we employed HeLa and Raji cells for these experiments. Given the differences focused around the P3 region, we focused on the general promoter region (P<sub>0</sub>, TSS, and P<sub>3</sub>) to test the differences between these cell lines. As observed for BAL17 cells, HeLa cells exhibited low AFF4 recruitment at this region in comparison to Raji cells (<a href="#pone-0087003-g006">Fig. 6B</a>). Consistent with AFF4 recruitment results, increased ELL2 occupancy near P<sub>3</sub> was seen in Raji cells compared to HeLa cells. MED26 occupancy showed a pattern similar to that of other SEC components with an increase, though more modest, near the P<sub>3</sub> promoter in Raji cells (<a href="#pone-0087003-g006">Fig. 6B</a>). Finally, we observed that Gdown1 followed a pattern similar to that of SEC and Mediator with an increase around the P<sub>3</sub> promoter in Raji cells (<a href="#pone-0087003-g006">Fig. 6B</a>).</p>
</div>
</div>

<div xmlns:plos="http://plos.org" id="section4" class="section toc-section"><a id="s4" name="s4" data-toc="s4" class="link-target" title="Discussion"></a><h2>Discussion</h2><a id="article1.body1.sec4.p1" name="article1.body1.sec4.p1" class="link-target"></a><p>Due to the importance of <em>MYC</em> in the genesis of hematopoietic malignancies, intense efforts have been directed for the past two decades toward understanding its regulation. Yet, given that <em>MYC</em> overexpression is caused by a plethora of genetic lesions, a uniform set of rules governing its transcriptional regulation is still missing. Recent advances in this area include the discovery of a small molecule inhibitor, JQ1 that decreases <em>MYC</em> expression and is therapeutically effective in pre-clinical animal models of midline carcinoma and in BL cells. However, JQ1 does not inhibit <em>MYC</em> expression to a similar extent in all cancer cells, further underscoring that <em>MYC</em> transcription is perhaps under different controls in various cancer cell types. Consistent with this notion, we discovered that JQ1 inhibits <em>MYC</em> expression in all BL-derived cells tested but does not inhibit <em>MYC</em> expression in some other cancer cell lines, as observed earlier (19). Because <em>MYC</em> deregulation can occur via different modes, we hypothesized that in distinct lymphoma phenotypes, high-level <em>MYC</em> expression may come under the controls of different transcriptional and epigenetic regulatory mechanisms, which may be sensitive or resistant to JQ1/Brd4 inhibition. In this study, we explored these mechanisms to establish <em>MYC</em> transcriptional and epigenetic signatures associated with particular cell types with the hope that these signatures will better define lymphoma subtypes and provide new therapeutic avenues to explore for clinically aggressive B cell lymphomas.</p>
<a id="article1.body1.sec4.p2" name="article1.body1.sec4.p2" class="link-target"></a><p>Although BL cells are a heterogeneous lot with differences in the length of Ig/MYC translocation that reportedly translate to variable levels of <em>MYC</em> overexpression <a href="#pone.0087003-Wilda1" class="ref-tip">[43]</a>, BL cells in our hands (<a href="#pone-0087003-g001">Fig. 1</a> and Figure S1, in <a href="#pone.0087003.s001">File S1</a>), and others <a href="#pone.0087003-Mertz1" class="ref-tip">[19]</a>, are uniformly susceptible to inhibition of <em>MYC</em> expression via Brd4 inhibition by JQ1. This inhibition appears to be regardless of whether these are EBV positive or negative BL lines (our study and ref 19). Brd4 is primarily associated with 5′-end promoters and enhancers <a href="#pone.0087003-Kellner1" class="ref-tip">[44]</a>, <a href="#pone.0087003-Loven1" class="ref-tip">[45]</a>, <a href="#pone.0087003-Zhang1" class="ref-tip">[46]</a>, and while we do see a more prominent level of Brd4 at the TSS in Raji cells (<a href="#pone-0087003-g002">Fig. 2</a>), we also observe Brd4 occupancy across the body of the <em>MYC</em> gene in JQ1 resistant cells (<a href="#pone-0087003-g002">Fig. 2</a>). One function of Brd4 is P-TEFb recruitment and P-TEFb occupancy does parallel Brd4-inhibitor sensitive <em>MYC</em> transcription, despite the fact that there is little difference in P-TEFb occupancy in untreated cells of either resistant or sensitive cells. Therefore, it appears that in cells resistant to JQ1, a Brd4-independent mechanism operates to recruit or retain P-TEFb and produce high levels of <em>MYC</em> transcription.</p>
<a id="article1.body1.sec4.p3" name="article1.body1.sec4.p3" class="link-target"></a><p>Because the SEC components AFF4 and ELL2 play a role in <em>MYC</em> regulation and transcriptional elongation, we hypothesized that an increase in these co-factors might relax Brd4 requirements. Surprisingly, their increased presence actually correlated with increased requirements for Brd4 (<a href="#pone-0087003-g006">Fig. 6</a>). The position of increased SEC components together with MED26 and Gdown1 around the P3 promoter suggests high transcriptional activity or a regulatory checkpoint in this region that is not present in cells that are resistant to JQ1 (summarized in <a href="#pone-0087003-g007">Figure 7</a>). It has been noted that in BL cells, due to <em>MYC-IG</em> translocation, the otherwise minor P3 promoter often becomes active and correlates with higher MYC expression <a href="#pone.0087003-Wilda1" class="ref-tip">[43]</a>. Coupled with the recent demonstration that the translocated <em>MYC</em> locus harbors super enhancers that are sensitive to JQ1 <a href="#pone.0087003-Loven1" class="ref-tip">[45]</a>, this raises the possibility that the mechanism of transcriptional regulation of <em>MYC</em> involving its native/non-translocated enhancer is different (<a href="#pone-0087003-g007">Fig. 7B</a>, Figure S2, in <a href="#pone.0087003.s001">File S1</a>).</p>
<a class="link-target" id="pone-0087003-g007" name="pone-0087003-g007"></a><div class="figure" data-doi="10.1371/journal.pone.0087003.g007"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&amp;id=10.1371/journal.pone.0087003.g007" data-doi="10.1371/journal.pone.0087003" data-uri="10.1371/journal.pone.0087003.g007"><img src="article/figure/image?size=inline&amp;id=10.1371/journal.pone.0087003.g007" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download">
          Download:
          <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0087003.g007"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&amp;size=large&amp;id=10.1371/journal.pone.0087003.g007"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&amp;size=original&amp;id=10.1371/journal.pone.0087003.g007"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Figure 7. </span> Proposed Model.</div><p class="caption_target"><a id="article1.body1.sec4.fig1.caption1.p1" name="article1.body1.sec4.fig1.caption1.p1" class="link-target"></a><p>(A) Summary of levels of factor occupancy spanning the <em>MYC</em> promoter P<sub>0,</sub> P<sub>1</sub>, P<sub>2</sub> and P<sub>3</sub> regions and associated with regulation of <em>MYC</em> transcription. (B) Graphical representation of proposed model of <em>MYC</em> transcription elongation regulation under different conditions–left panel shows non-translocated <em>MYC</em> locus and right panel depicts <em>IGH-MYC</em> translocated locus.</p>
</p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0087003.g007">
              https://doi.org/10.1371/journal.pone.0087003.g007</a></p></div><a id="article1.body1.sec4.p4" name="article1.body1.sec4.p4" class="link-target"></a><p>Regulation of transcription at the <em>MYC</em> minor promoters, including P3, has been shown to involve the P-TEFb regulator 7SK snRNA, which participates in transformation-dependent <em>MYC</em> deregulation <a href="#pone.0087003-Peterlin1" class="ref-tip">[47]</a>. 7SK snRNA is a complex of RNA and proteins such as LARP7 and HEXIM1 that are known to stabilize P-TEFb in an inactive form <a href="#pone.0087003-Zhou1" class="ref-tip">[13]</a>, <a href="#pone.0087003-Guo1" class="ref-tip">[14]</a>, <a href="#pone.0087003-Peterlin1" class="ref-tip">[47]</a>. JQ1 also leads to the release of P-TEFb from the 7SK snRNP and to HIV gene expression that involves an increase in AFF4 and ELL2 <a href="#pone.0087003-Bartholomeeusen1" class="ref-tip">[48]</a>, <a href="#pone.0087003-Levens1" class="ref-tip">[49]</a>. Moreover, while JQ1 inhibited <em>MYC</em> expression in BL lines tested, it enhanced BCR stimulated induced transcription of c-<em>fos</em> in these cells (Figure S1, in <a href="#pone.0087003.s001">File S1</a>). Thus, the effects of Brd4 inhibition by JQ1 appear more complicated than has been previously anticipated.</p>
<a id="article1.body1.sec4.p5" name="article1.body1.sec4.p5" class="link-target"></a><p>Much is known about the different <em>MYC</em> promoters and their possible functions in oncogenesis. BAL17 and HeLa cells may behave like GLC4 cells, where <em>MYC</em> is transcribed at a high rate but not grossly rearranged <a href="#pone.0087003-Dooley1" class="ref-tip">[50]</a>. That <em>MYC</em> transcription in GLC4 is reported to initiate mainly from P1 instead of the P2 promoter and that this promoter shift seems to overcome transcript termination at a transcriptional pause site described for Burkitt’s lymphoma <a href="#pone.0087003-Dooley1" class="ref-tip">[50]</a>. In the future, it will be interesting to conclusively determine if any difference in cell-specific primary transcription and <em>MYC</em> promoter usage is driving, or being driven by, the differences in transcriptional elongation regulation we report here. Point mutations could also play a role in differential JQ1 sensitivity though a search of available UCSC Genome Browser tracks only finds one SNP reported in the general vicinity of the P1/P2 promoter (data not shown).</p>
<a id="article1.body1.sec4.p6" name="article1.body1.sec4.p6" class="link-target"></a><p>Altered regulation at the elongation stage of transcription has been proposed to contribute to leukemic pathogenesis <a href="#pone.0087003-Lin2" class="ref-tip">[29]</a>, <a href="#pone.0087003-Mohan1" class="ref-tip">[51]</a>. While many PRGs such as <em>MYC</em> have a well-recognized checkpoint at +40 to the TSS that is associated with paused transcription <a href="#pone.0087003-Levine1" class="ref-tip">[52]</a>, <a href="#pone.0087003-Nechaev1" class="ref-tip">[53]</a>, our data indicate that an additional potential checkpoint near the region around P3 may be utilized differently depending upon the mode of <em>MYC</em> overexpression. In the near future, we hope to employ different <em>MYC</em>-driven lymphoma samples to test whether the transcriptional signatures that we observe here correlate with the particular <em>MYC</em> genetic lesion (translocated versus non-translocated).</p>
</div>

<div xmlns:plos="http://plos.org" id="section5" class="section toc-section"><a id="s5" name="s5" data-toc="s5" class="link-target" title="Supporting Information"></a><h2>Supporting Information</h2><div class="figshare_widget" doi="10.1371/journal.pone.0087003"></div><div class="supplementary-material"><a name="pone.0087003.s001" id="pone.0087003.s001" class="link-target"></a><h3 class="siTitle title-small"><a href="article/file?type=supplementary&amp;id=10.1371/journal.pone.0087003.s001">File S1. </a></h3><a id="article1.body1.sec5.supplementary-material1.caption1.p1" name="article1.body1.sec5.supplementary-material1.caption1.p1" class="link-target"></a><p class="preSiDOI"><strong>File includes Figures S1–S3.</strong> Figure S1. Effect of JQ1 on <em>MYC</em> and <em>Fos</em> expression. (A) Effect of JQ1 on Ramos BL cell line in the absence of any stimulation. (B) The reported cell lines were incubated at 37<sup>C</sup> with 1 µM JQ1 for 2 hours prior to addition of 10 µM of anti-mouse IgM fragments, which triggers the B cell receptor (BCR). After 30 minutes stimulation, RNA was harvested and analyzed for c-<em>fos</em>, c-<em>myc</em> and ActB mRNA expression as detailed in Materials and Methods. The experiments were performed in triplicate and reported as the mean and standard deviation of the ratio of target mRNA over ActB mRNA. Figure S2. RNA Pol II occupancy at the MYC locus in Raji and HeLa cells. ChIP-seq data–ENCONDE UCSC Genome Browser tracks of Polymerase II occupancy at the <em>MYC</em> locus in HeLa and Raji cells. Figure S3. Primer positions and sequences used for ChIP across mouse and human <em>MYC</em> locus.</p>
<p class="siDoi"><a href="https://doi.org/10.1371/journal.pone.0087003.s001">https://doi.org/10.1371/journal.pone.0087003.s001</a></p><a id="article1.body1.sec5.supplementary-material1.caption1.p2" name="article1.body1.sec5.supplementary-material1.caption1.p2" class="link-target"></a><p class="postSiDOI">(PDF)</p>
</div></div>





<div xmlns:plos="http://plos.org" class="section toc-section"><a id="ack" name="ack" data-toc="ack" title="Acknowledgments" class="link-target"></a><h2>Acknowledgments</h2>
<a id="article1.back1.ack1.p1" name="article1.back1.ack1.p1" class="link-target"></a><p>We thank members of our laboratories for help with this manuscript.</p>
</div><div xmlns:plos="http://plos.org" class="contributions toc-section"><a id="authcontrib" name="authcontrib" data-toc="authcontrib" title="Author Contributions"></a><h2>Author Contributions</h2><p>Conceived and designed the experiments: TF ALR. Performed the experiments: TF PG. Analyzed the data: DHP RC JC C-MC JEB AS. Contributed reagents/materials/analysis tools: DHP RC JC C-MC JEB AS. Wrote the paper: TF ALR. Helped with review and revision of the manuscript: DHP RC JC C-MC JEB AS.</p></div><div xmlns:plos="http://plos.org" class="toc-section"><a id="references" name="references" class="link-target" data-toc="references" title="References"></a><h2>References</h2><ol class="references"><li id="ref1"><span class="order">1.
            </span><a name="pone.0087003-Young1" id="pone.0087003-Young1" class="link-target"></a>Young RM, Turner BC, Refaeli Y (2008) B-cell receptor signaling in the genesis and maintenance of B-cell lymphoma. Future Oncol 4: 591–594. <ul class="reflinks"><li><a href="#" data-author="Young" data-cit="YoungRM%2C%20TurnerBC%2C%20RefaeliY%20%282008%29%20B-cell%20receptor%20signaling%20in%20the%20genesis%20and%20maintenance%20of%20B-cell%20lymphoma.%20Future%20Oncol%204%3A%20591%E2%80%93594." data-title="B-cell%20receptor%20signaling%20in%20the%20genesis%20and%20maintenance%20of%20B-cell%20lymphoma" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=B-cell+receptor+signaling+in+the+genesis+and+maintenance+of+B-cell+lymphoma+Young+2008" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref2"><span class="order">2.
            </span><a name="pone.0087003-Refaeli1" id="pone.0087003-Refaeli1" class="link-target"></a>Refaeli Y, Young RM, Turner BC, Duda J, Field KA, et al. (2008) The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas. PLoS Biol 6: e152. <ul class="reflinks"><li><a href="#" data-author="Refaeli" data-cit="RefaeliY%2C%20YoungRM%2C%20TurnerBC%2C%20DudaJ%2C%20FieldKA%2C%20et%20al.%20%282008%29%20The%20B%20cell%20antigen%20receptor%20and%20overexpression%20of%20MYC%20can%20cooperate%20in%20the%20genesis%20of%20B%20cell%20lymphomas.%20PLoS%20Biol%206%3A%20e152." data-title="The%20B%20cell%20antigen%20receptor%20and%20overexpression%20of%20MYC%20can%20cooperate%20in%20the%20genesis%20of%20B%20cell%20lymphomas" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=The+B+cell+antigen+receptor+and+overexpression+of+MYC+can+cooperate+in+the+genesis+of+B+cell+lymphomas+Refaeli+2008" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref3"><span class="order">3.
            </span><a name="pone.0087003-Shaffer1" id="pone.0087003-Shaffer1" class="link-target"></a>Shaffer AL 3rd, Young RM, Staudt LM (2012) Pathogenesis of human B cell lymphomas. Annu Rev Immunol 30: 565–610. <ul class="reflinks"><li><a href="#" data-author="Shaffer" data-cit="ShafferAL3rd%2C%20YoungRM%2C%20StaudtLM%20%282012%29%20Pathogenesis%20of%20human%20B%20cell%20lymphomas.%20Annu%20Rev%20Immunol%2030%3A%20565%E2%80%93610." data-title="Pathogenesis%20of%20human%20B%20cell%20lymphomas" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Pathogenesis+of+human+B+cell+lymphomas+Shaffer+2012" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref4"><span class="order">4.
            </span><a name="pone.0087003-Schrader1" id="pone.0087003-Schrader1" class="link-target"></a>Schrader A, Bentink S, Spang R, Lenze D, Hummel M, et al. (2012) High Myc activity is an independent negative prognostic factor for diffuse large B cell lymphomas. Int J Cancer 131: E348–361. <ul class="reflinks"><li><a href="#" data-author="Schrader" data-cit="SchraderA%2C%20BentinkS%2C%20SpangR%2C%20LenzeD%2C%20HummelM%2C%20et%20al.%20%282012%29%20High%20Myc%20activity%20is%20an%20independent%20negative%20prognostic%20factor%20for%20diffuse%20large%20B%20cell%20lymphomas.%20Int%20J%20Cancer%20131%3A%20E348%E2%80%93361." data-title="High%20Myc%20activity%20is%20an%20independent%20negative%20prognostic%20factor%20for%20diffuse%20large%20B%20cell%20lymphomas" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=High+Myc+activity+is+an+independent+negative+prognostic+factor+for+diffuse+large+B+cell+lymphomas+Schrader+2012" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref5"><span class="order">5.
            </span><a name="pone.0087003-Ahmadiyeh1" id="pone.0087003-Ahmadiyeh1" class="link-target"></a>Ahmadiyeh N, Pomerantz MM, Grisanzio C, Herman P, Jia L, et al. (2010) 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proc Natl Acad Sci U S A 107: 9742–9746. <ul class="reflinks"><li><a href="#" data-author="Ahmadiyeh" data-cit="AhmadiyehN%2C%20PomerantzMM%2C%20GrisanzioC%2C%20HermanP%2C%20JiaL%2C%20et%20al.%20%282010%29%208q24%20prostate%2C%20breast%2C%20and%20colon%20cancer%20risk%20loci%20show%20tissue-specific%20long-range%20interaction%20with%20MYC.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A%20107%3A%209742%E2%80%939746." data-title="8q24%20prostate%2C%20breast%2C%20and%20colon%20cancer%20risk%20loci%20show%20tissue-specific%20long-range%20interaction%20with%20MYC" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=8q24+prostate%2C+breast%2C+and+colon+cancer+risk+loci+show+tissue-specific+long-range+interaction+with+MYC+Ahmadiyeh+2010" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref6"><span class="order">6.
            </span><a name="pone.0087003-Selvanayagam1" id="pone.0087003-Selvanayagam1" class="link-target"></a>Selvanayagam P, Blick M, Narni F, van Tuinen P, Ledbetter DH, et al. (1988) Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma. Blood 71: 30–35. <ul class="reflinks"><li><a href="#" data-author="Selvanayagam" data-cit="SelvanayagamP%2C%20BlickM%2C%20NarniF%2C%20van%20TuinenP%2C%20LedbetterDH%2C%20et%20al.%20%281988%29%20Alteration%20and%20abnormal%20expression%20of%20the%20c-myc%20oncogene%20in%20human%20multiple%20myeloma.%20Blood%2071%3A%2030%E2%80%9335." data-title="Alteration%20and%20abnormal%20expression%20of%20the%20c-myc%20oncogene%20in%20human%20multiple%20myeloma" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Alteration+and+abnormal+expression+of+the+c-myc+oncogene+in+human+multiple+myeloma+Selvanayagam+1988" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref7"><span class="order">7.
            </span><a name="pone.0087003-Dang1" id="pone.0087003-Dang1" class="link-target"></a>Dang CV (2012) MYC on the path to cancer. Cell 149: 22–35. <ul class="reflinks"><li><a href="#" data-author="Dang" data-cit="DangCV%20%282012%29%20MYC%20on%20the%20path%20to%20cancer.%20Cell%20149%3A%2022%E2%80%9335." data-title="MYC%20on%20the%20path%20to%20cancer" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=MYC+on+the+path+to+cancer+Dang+2012" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref8"><span class="order">8.
            </span><a name="pone.0087003-Lin1" id="pone.0087003-Lin1" class="link-target"></a>Lin CY, Loven J, Rahl PB, Paranal RM, Burge CB, et al. (2012) Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151: 56–67. <ul class="reflinks"><li><a href="#" data-author="Lin" data-cit="LinCY%2C%20LovenJ%2C%20RahlPB%2C%20ParanalRM%2C%20BurgeCB%2C%20et%20al.%20%282012%29%20Transcriptional%20amplification%20in%20tumor%20cells%20with%20elevated%20c-Myc.%20Cell%20151%3A%2056%E2%80%9367." data-title="Transcriptional%20amplification%20in%20tumor%20cells%20with%20elevated%20c-Myc" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Transcriptional+amplification+in+tumor+cells+with+elevated+c-Myc+Lin+2012" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref9"><span class="order">9.
            </span><a name="pone.0087003-Nie1" id="pone.0087003-Nie1" class="link-target"></a>Nie Z, Hu G, Wei G, Cui K, Yamane A, et al. (2012) c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151: 68–79. <ul class="reflinks"><li><a href="#" data-author="Nie" data-cit="NieZ%2C%20HuG%2C%20WeiG%2C%20CuiK%2C%20YamaneA%2C%20et%20al.%20%282012%29%20c-Myc%20is%20a%20universal%20amplifier%20of%20expressed%20genes%20in%20lymphocytes%20and%20embryonic%20stem%20cells.%20Cell%20151%3A%2068%E2%80%9379." data-title="c-Myc%20is%20a%20universal%20amplifier%20of%20expressed%20genes%20in%20lymphocytes%20and%20embryonic%20stem%20cells" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=c-Myc+is+a+universal+amplifier+of+expressed+genes+in+lymphocytes+and+embryonic+stem+cells+Nie+2012" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref10"><span class="order">10.
            </span><a name="pone.0087003-Fowler1" id="pone.0087003-Fowler1" class="link-target"></a>Fowler T, Sen R, Roy AL (2011) Regulation of primary response genes. Mol Cell 44: 348–360. <ul class="reflinks"><li><a href="#" data-author="Fowler" data-cit="FowlerT%2C%20SenR%2C%20RoyAL%20%282011%29%20Regulation%20of%20primary%20response%20genes.%20Mol%20Cell%2044%3A%20348%E2%80%93360." data-title="Regulation%20of%20primary%20response%20genes" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Regulation+of+primary+response+genes+Fowler+2011" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref11"><span class="order">11.
            </span><a name="pone.0087003-Muller1" id="pone.0087003-Muller1" class="link-target"></a>Muller S, Filippakopoulos P, Knapp S (2011) Bromodomains as therapeutic targets. Expert Rev Mol Med 13: e29. <ul class="reflinks"><li><a href="#" data-author="Muller" data-cit="MullerS%2C%20FilippakopoulosP%2C%20KnappS%20%282011%29%20Bromodomains%20as%20therapeutic%20targets.%20Expert%20Rev%20Mol%20Med%2013%3A%20e29." data-title="Bromodomains%20as%20therapeutic%20targets" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Bromodomains+as+therapeutic+targets+Muller+2011" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref12"><span class="order">12.
            </span><a name="pone.0087003-Dey1" id="pone.0087003-Dey1" class="link-target"></a>Dey A, Chitsaz F, Abbasi A, Misteli T, Ozato K (2003) The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc Natl Acad Sci U S A 100: 8758–8763. <ul class="reflinks"><li><a href="#" data-author="Dey" data-cit="DeyA%2C%20ChitsazF%2C%20AbbasiA%2C%20MisteliT%2C%20OzatoK%20%282003%29%20The%20double%20bromodomain%20protein%20Brd4%20binds%20to%20acetylated%20chromatin%20during%20interphase%20and%20mitosis.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A%20100%3A%208758%E2%80%938763." data-title="The%20double%20bromodomain%20protein%20Brd4%20binds%20to%20acetylated%20chromatin%20during%20interphase%20and%20mitosis" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=The+double+bromodomain+protein+Brd4+binds+to+acetylated+chromatin+during+interphase+and+mitosis+Dey+2003" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref13"><span class="order">13.
            </span><a name="pone.0087003-Zhou1" id="pone.0087003-Zhou1" class="link-target"></a>Zhou Q, Li T, Price DH (2012) RNA polymerase II elongation control. Annu Rev Biochem 81: 119–143. <ul class="reflinks"><li><a href="#" data-author="Zhou" data-cit="ZhouQ%2C%20LiT%2C%20PriceDH%20%282012%29%20RNA%20polymerase%20II%20elongation%20control.%20Annu%20Rev%20Biochem%2081%3A%20119%E2%80%93143." data-title="RNA%20polymerase%20II%20elongation%20control" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=RNA+polymerase+II+elongation+control+Zhou+2012" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref14"><span class="order">14.
            </span><a name="pone.0087003-Guo1" id="pone.0087003-Guo1" class="link-target"></a>Guo J, Price DH (2013) RNA Polymerase II Transcription Elongation Control. Chem Rev. 113: 8583–603. <ul class="reflinks"><li><a href="#" data-author="Guo" data-cit="GuoJ%2C%20PriceDH%20%282013%29%20RNA%20Polymerase%20II%20Transcription%20Elongation%20Control.%20Chem%20Rev.%20113%3A%208583%E2%80%93603." data-title="RNA%20Polymerase%20II%20Transcription%20Elongation%20Control.%20Chem%20Rev" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=RNA+Polymerase+II+Transcription+Elongation+Control.+Chem+Rev+Guo+2013" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref15"><span class="order">15.
            </span><a name="pone.0087003-Miyoshi1" id="pone.0087003-Miyoshi1" class="link-target"></a>Miyoshi S, Ooike S, Iwata K, Hikawa H, Sugaraha K (2009). International Patent No. PCT/JP2008/073864 (WO/2009/084693). <ul class="find-nolinks"></ul></li><li id="ref16"><span class="order">16.
            </span><a name="pone.0087003-Delmore1" id="pone.0087003-Delmore1" class="link-target"></a>Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, et al. (2011) BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146: 904–917. <ul class="reflinks"><li><a href="#" data-author="Delmore" data-cit="DelmoreJE%2C%20IssaGC%2C%20LemieuxME%2C%20RahlPB%2C%20ShiJ%2C%20et%20al.%20%282011%29%20BET%20bromodomain%20inhibition%20as%20a%20therapeutic%20strategy%20to%20target%20c-Myc.%20Cell%20146%3A%20904%E2%80%93917." data-title="BET%20bromodomain%20inhibition%20as%20a%20therapeutic%20strategy%20to%20target%20c-Myc" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=BET+bromodomain+inhibition+as+a+therapeutic+strategy+to+target+c-Myc+Delmore+2011" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref17"><span class="order">17.
            </span><a name="pone.0087003-Filippakopoulos1" id="pone.0087003-Filippakopoulos1" class="link-target"></a>Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, et al. (2010) Selective inhibition of BET bromodomains. Nature 468: 1067–1073. <ul class="reflinks"><li><a href="#" data-author="Filippakopoulos" data-cit="FilippakopoulosP%2C%20QiJ%2C%20PicaudS%2C%20ShenY%2C%20SmithWB%2C%20et%20al.%20%282010%29%20Selective%20inhibition%20of%20BET%20bromodomains.%20Nature%20468%3A%201067%E2%80%931073." data-title="Selective%20inhibition%20of%20BET%20bromodomains" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Selective+inhibition+of+BET+bromodomains+Filippakopoulos+2010" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref18"><span class="order">18.
            </span><a name="pone.0087003-Nicodeme1" id="pone.0087003-Nicodeme1" class="link-target"></a>Nicodeme E, Jeffrey KL, Schaefer U, Beinke S, Dewell S, et al. (2010) Suppression of inflammation by a synthetic histone mimic. Nature 468: 1119–1123. <ul class="reflinks"><li><a href="#" data-author="Nicodeme" data-cit="NicodemeE%2C%20JeffreyKL%2C%20SchaeferU%2C%20BeinkeS%2C%20DewellS%2C%20et%20al.%20%282010%29%20Suppression%20of%20inflammation%20by%20a%20synthetic%20histone%20mimic.%20Nature%20468%3A%201119%E2%80%931123." data-title="Suppression%20of%20inflammation%20by%20a%20synthetic%20histone%20mimic" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Suppression+of+inflammation+by+a+synthetic+histone+mimic+Nicodeme+2010" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref19"><span class="order">19.
            </span><a name="pone.0087003-Mertz1" id="pone.0087003-Mertz1" class="link-target"></a>Mertz JA, Conery AR, Bryant BM, Sandy P, Balasubramanian S, et al. (2011) Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc Natl Acad Sci U S A 108: 16669–16674. <ul class="reflinks"><li><a href="#" data-author="Mertz" data-cit="MertzJA%2C%20ConeryAR%2C%20BryantBM%2C%20SandyP%2C%20BalasubramanianS%2C%20et%20al.%20%282011%29%20Targeting%20MYC%20dependence%20in%20cancer%20by%20inhibiting%20BET%20bromodomains.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A%20108%3A%2016669%E2%80%9316674." data-title="Targeting%20MYC%20dependence%20in%20cancer%20by%20inhibiting%20BET%20bromodomains" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Targeting+MYC+dependence+in+cancer+by+inhibiting+BET+bromodomains+Mertz+2011" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref20"><span class="order">20.
            </span><a name="pone.0087003-Kim1" id="pone.0087003-Kim1" class="link-target"></a>Kim KJ, Kanellopoulos-Langevin C, Merwin RM, Sachs DH, Asofsky R (1979) Establishment and characterization of BALB/c lymphoma lines with B cell properties. J Immunol 122: 549–554. <ul class="reflinks"><li><a href="#" data-author="Kim" data-cit="KimKJ%2C%20Kanellopoulos-LangevinC%2C%20MerwinRM%2C%20SachsDH%2C%20AsofskyR%20%281979%29%20Establishment%20and%20characterization%20of%20BALB%2Fc%20lymphoma%20lines%20with%20B%20cell%20properties.%20J%20Immunol%20122%3A%20549%E2%80%93554." data-title="Establishment%20and%20characterization%20of%20BALB%2Fc%20lymphoma%20lines%20with%20B%20cell%20properties" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Establishment+and+characterization+of+BALB%2Fc+lymphoma+lines+with+B+cell+properties+Kim+1979" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref21"><span class="order">21.
            </span><a name="pone.0087003-Takada1" id="pone.0087003-Takada1" class="link-target"></a>Takada K, Ono Y (1989) Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J Virol 63: 445–449. <ul class="reflinks"><li><a href="#" data-author="Takada" data-cit="TakadaK%2C%20OnoY%20%281989%29%20Synchronous%20and%20sequential%20activation%20of%20latently%20infected%20Epstein-Barr%20virus%20genomes.%20J%20Virol%2063%3A%20445%E2%80%93449." data-title="Synchronous%20and%20sequential%20activation%20of%20latently%20infected%20Epstein-Barr%20virus%20genomes" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Synchronous+and+sequential+activation+of+latently+infected+Epstein-Barr+virus+genomes+Takada+1989" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref22"><span class="order">22.
            </span><a name="pone.0087003-Pulvertaft1" id="pone.0087003-Pulvertaft1" class="link-target"></a>Pulvertaft JV (1964) Cytology of Burkitt’s Tumour (African Lymphoma). Lancet 1: 238–240. <ul class="reflinks"><li><a href="#" data-author="Pulvertaft" data-cit="PulvertaftJV%20%281964%29%20Cytology%20of%20Burkitt%E2%80%99s%20Tumour%20%28African%20Lymphoma%29.%20Lancet%201%3A%20238%E2%80%93240." data-title="Cytology%20of%20Burkitt%E2%80%99s%20Tumour%20%28African%20Lymphoma%29" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Cytology+of+Burkitt%E2%80%99s+Tumour+%28African+Lymphoma%29+Pulvertaft+1964" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref23"><span class="order">23.
            </span><a name="pone.0087003-Clements1" id="pone.0087003-Clements1" class="link-target"></a>Clements GB, Klein G, Povey S (1975) Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA. Int J Cancer 16: 125–133. <ul class="reflinks"><li><a href="#" data-author="Clements" data-cit="ClementsGB%2C%20KleinG%2C%20PoveyS%20%281975%29%20Production%20by%20EBV%20infection%20of%20an%20EBNA-positive%20subline%20from%20an%20EBNA-negative%20human%20lymphoma%20cell%20line%20without%20detectable%20EBV%20DNA.%20Int%20J%20Cancer%2016%3A%20125%E2%80%93133." data-title="Production%20by%20EBV%20infection%20of%20an%20EBNA-positive%20subline%20from%20an%20EBNA-negative%20human%20lymphoma%20cell%20line%20without%20detectable%20EBV%20DNA" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Production+by+EBV+infection+of+an+EBNA-positive+subline+from+an+EBNA-negative+human+lymphoma+cell+line+without+detectable+EBV+DNA+Clements+1975" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref24"><span class="order">24.
            </span><a name="pone.0087003-Puck1" id="pone.0087003-Puck1" class="link-target"></a>Puck TT, Fisher HW (1956) Genetics of Somatic Mammalian Cells: I. Demonstration of the Existence of Mutants with Different Growth Requirements in a Human Cancer Cell Strain (Hela). J Exp Med 104: 427–434. <ul class="reflinks"><li><a href="#" data-author="Puck" data-cit="PuckTT%2C%20FisherHW%20%281956%29%20Genetics%20of%20Somatic%20Mammalian%20Cells%3A%20I.%20Demonstration%20of%20the%20Existence%20of%20Mutants%20with%20Different%20Growth%20Requirements%20in%20a%20Human%20Cancer%20Cell%20Strain%20%28Hela%29.%20J%20Exp%20Med%20104%3A%20427%E2%80%93434." data-title="Genetics%20of%20Somatic%20Mammalian%20Cells%3A%20I.%20Demonstration%20of%20the%20Existence%20of%20Mutants%20with%20Different%20Growth%20Requirements%20in%20a%20Human%20Cancer%20Cell%20Strain%20%28Hela%29" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Genetics+of+Somatic+Mammalian+Cells%3A+I.+Demonstration+of+the+Existence+of+Mutants+with+Different+Growth+Requirements+in+a+Human+Cancer+Cell+Strain+%28Hela%29+Puck+1956" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref25"><span class="order">25.
            </span><a name="pone.0087003-Fowler2" id="pone.0087003-Fowler2" class="link-target"></a>Fowler T, Suh H, Buratowski S, Roy AL (2013) Regulation of primary response genes in B cells. J Biol Chem 288: 14906–14916. <ul class="reflinks"><li><a href="#" data-author="Fowler" data-cit="FowlerT%2C%20SuhH%2C%20BuratowskiS%2C%20RoyAL%20%282013%29%20Regulation%20of%20primary%20response%20genes%20in%20B%20cells.%20J%20Biol%20Chem%20288%3A%2014906%E2%80%9314916." data-title="Regulation%20of%20primary%20response%20genes%20in%20B%20cells" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Regulation+of+primary+response+genes+in+B+cells+Fowler+2013" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref26"><span class="order">26.
            </span><a name="pone.0087003-Wu1" id="pone.0087003-Wu1" class="link-target"></a>Wu SY, Lee AY, Lai HT, Zhang H, Chiang CM (2013) Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting. Mol Cell 49: 843–857. <ul class="reflinks"><li><a href="#" data-author="Wu" data-cit="WuSY%2C%20LeeAY%2C%20LaiHT%2C%20ZhangH%2C%20ChiangCM%20%282013%29%20Phospho%20switch%20triggers%20Brd4%20chromatin%20binding%20and%20activator%20recruitment%20for%20gene-specific%20targeting.%20Mol%20Cell%2049%3A%20843%E2%80%93857." data-title="Phospho%20switch%20triggers%20Brd4%20chromatin%20binding%20and%20activator%20recruitment%20for%20gene-specific%20targeting" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Phospho+switch+triggers+Brd4+chromatin+binding+and+activator+recruitment+for+gene-specific+targeting+Wu+2013" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref27"><span class="order">27.
            </span><a name="pone.0087003-Wu2" id="pone.0087003-Wu2" class="link-target"></a>Wu SY, Lee AY, Hou SY, Kemper JK, Erdjument-Bromage H, et al. (2006) Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev 20: 2383–2396. <ul class="reflinks"><li><a href="#" data-author="Wu" data-cit="WuSY%2C%20LeeAY%2C%20HouSY%2C%20KemperJK%2C%20Erdjument-BromageH%2C%20et%20al.%20%282006%29%20Brd4%20links%20chromatin%20targeting%20to%20HPV%20transcriptional%20silencing.%20Genes%20Dev%2020%3A%202383%E2%80%932396." data-title="Brd4%20links%20chromatin%20targeting%20to%20HPV%20transcriptional%20silencing" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Brd4+links+chromatin+targeting+to+HPV+transcriptional+silencing+Wu+2006" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref28"><span class="order">28.
            </span><a name="pone.0087003-Cheng1" id="pone.0087003-Cheng1" class="link-target"></a>Cheng B, Li T, Rahl PB, Adamson TE, Loudas NB, et al. (2012) Functional association of Gdown1 with RNA polymerase II poised on human genes. Mol Cell 45: 38–50. <ul class="reflinks"><li><a href="#" data-author="Cheng" data-cit="ChengB%2C%20LiT%2C%20RahlPB%2C%20AdamsonTE%2C%20LoudasNB%2C%20et%20al.%20%282012%29%20Functional%20association%20of%20Gdown1%20with%20RNA%20polymerase%20II%20poised%20on%20human%20genes.%20Mol%20Cell%2045%3A%2038%E2%80%9350." data-title="Functional%20association%20of%20Gdown1%20with%20RNA%20polymerase%20II%20poised%20on%20human%20genes" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Functional+association+of+Gdown1+with+RNA+polymerase+II+poised+on+human+genes+Cheng+2012" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref29"><span class="order">29.
            </span><a name="pone.0087003-Lin2" id="pone.0087003-Lin2" class="link-target"></a>Lin C, Smith ER, Takahashi H, Lai KC, Martin-Brown S, et al. (2010) AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia. Mol Cell 37: 429–437. <ul class="reflinks"><li><a href="#" data-author="Lin" data-cit="LinC%2C%20SmithER%2C%20TakahashiH%2C%20LaiKC%2C%20Martin-BrownS%2C%20et%20al.%20%282010%29%20AFF4%2C%20a%20component%20of%20the%20ELL%2FP-TEFb%20elongation%20complex%20and%20a%20shared%20subunit%20of%20MLL%20chimeras%2C%20can%20link%20transcription%20elongation%20to%20leukemia.%20Mol%20Cell%2037%3A%20429%E2%80%93437." data-title="AFF4%2C%20a%20component%20of%20the%20ELL%2FP-TEFb%20elongation%20complex%20and%20a%20shared%20subunit%20of%20MLL%20chimeras%2C%20can%20link%20transcription%20elongation%20to%20leukemia" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=AFF4%2C+a+component+of+the+ELL%2FP-TEFb+elongation+complex+and+a+shared+subunit+of+MLL+chimeras%2C+can+link+transcription+elongation+to+leukemia+Lin+2010" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref30"><span class="order">30.
            </span><a name="pone.0087003-Maguire1" id="pone.0087003-Maguire1" class="link-target"></a>Maguire RT, Robins TS, Thorgeirsson SS, Heilman CA (1983) Expression of cellular myc and mos genes in undifferentiated B cell lymphomas of Burkitt and non-Burkitt types. Proc Natl Acad Sci U S A 80: 1947–1950. <ul class="reflinks"><li><a href="#" data-author="Maguire" data-cit="MaguireRT%2C%20RobinsTS%2C%20ThorgeirssonSS%2C%20HeilmanCA%20%281983%29%20Expression%20of%20cellular%20myc%20and%20mos%20genes%20in%20undifferentiated%20B%20cell%20lymphomas%20of%20Burkitt%20and%20non-Burkitt%20types.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A%2080%3A%201947%E2%80%931950." data-title="Expression%20of%20cellular%20myc%20and%20mos%20genes%20in%20undifferentiated%20B%20cell%20lymphomas%20of%20Burkitt%20and%20non-Burkitt%20types" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Expression+of+cellular+myc+and+mos+genes+in+undifferentiated+B+cell+lymphomas+of+Burkitt+and+non-Burkitt+types+Maguire+1983" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref31"><span class="order">31.
            </span><a name="pone.0087003-Bhatt1" id="pone.0087003-Bhatt1" class="link-target"></a>Bhatt DM, Pandya-Jones A, Tong AJ, Barozzi I, Lissner MM, et al. (2012) Transcript dynamics of proinflammatory genes revealed by sequence analysis of subcellular RNA fractions. Cell 150: 279–290. <ul class="reflinks"><li><a href="#" data-author="Bhatt" data-cit="BhattDM%2C%20Pandya-JonesA%2C%20TongAJ%2C%20BarozziI%2C%20LissnerMM%2C%20et%20al.%20%282012%29%20Transcript%20dynamics%20of%20proinflammatory%20genes%20revealed%20by%20sequence%20analysis%20of%20subcellular%20RNA%20fractions.%20Cell%20150%3A%20279%E2%80%93290." data-title="Transcript%20dynamics%20of%20proinflammatory%20genes%20revealed%20by%20sequence%20analysis%20of%20subcellular%20RNA%20fractions" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Transcript+dynamics+of+proinflammatory+genes+revealed+by+sequence+analysis+of+subcellular+RNA+fractions+Bhatt+2012" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref32"><span class="order">32.
            </span><a name="pone.0087003-Seila1" id="pone.0087003-Seila1" class="link-target"></a>Seila AC, Core LJ, Lis JT, Sharp PA (2009) Divergent transcription: a new feature of active promoters. Cell Cycle 8: 2557–2564. <ul class="reflinks"><li><a href="#" data-author="Seila" data-cit="SeilaAC%2C%20CoreLJ%2C%20LisJT%2C%20SharpPA%20%282009%29%20Divergent%20transcription%3A%20a%20new%20feature%20of%20active%20promoters.%20Cell%20Cycle%208%3A%202557%E2%80%932564." data-title="Divergent%20transcription%3A%20a%20new%20feature%20of%20active%20promoters" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Divergent+transcription%3A+a+new+feature+of+active+promoters+Seila+2009" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref33"><span class="order">33.
            </span><a name="pone.0087003-Klemsz1" id="pone.0087003-Klemsz1" class="link-target"></a>Klemsz MJ, Justement LB, Palmer E, Cambier JC (1989) Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands. J Immunol 143: 1032–1039. <ul class="reflinks"><li><a href="#" data-author="Klemsz" data-cit="KlemszMJ%2C%20JustementLB%2C%20PalmerE%2C%20CambierJC%20%281989%29%20Induction%20of%20c-fos%20and%20c-myc%20expression%20during%20B%20cell%20activation%20by%20IL-4%20and%20immunoglobulin%20binding%20ligands.%20J%20Immunol%20143%3A%201032%E2%80%931039." data-title="Induction%20of%20c-fos%20and%20c-myc%20expression%20during%20B%20cell%20activation%20by%20IL-4%20and%20immunoglobulin%20binding%20ligands" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Induction+of+c-fos+and+c-myc+expression+during+B+cell+activation+by+IL-4+and+immunoglobulin+binding+ligands+Klemsz+1989" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref34"><span class="order">34.
            </span><a name="pone.0087003-Lee1" id="pone.0087003-Lee1" class="link-target"></a>Lee BK, Bhinge AA, Battenhouse A, McDaniell RM, Liu Z, et al. (2012) Cell-type specific and combinatorial usage of diverse transcription factors revealed by genome-wide binding studies in multiple human cells. Genome Res 22: 9–24. <ul class="reflinks"><li><a href="#" data-author="Lee" data-cit="LeeBK%2C%20BhingeAA%2C%20BattenhouseA%2C%20McDaniellRM%2C%20LiuZ%2C%20et%20al.%20%282012%29%20Cell-type%20specific%20and%20combinatorial%20usage%20of%20diverse%20transcription%20factors%20revealed%20by%20genome-wide%20binding%20studies%20in%20multiple%20human%20cells.%20Genome%20Res%2022%3A%209%E2%80%9324." data-title="Cell-type%20specific%20and%20combinatorial%20usage%20of%20diverse%20transcription%20factors%20revealed%20by%20genome-wide%20binding%20studies%20in%20multiple%20human%20cells" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Cell-type+specific+and+combinatorial+usage+of+diverse+transcription+factors+revealed+by+genome-wide+binding+studies+in+multiple+human+cells+Lee+2012" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref35"><span class="order">35.
            </span><a name="pone.0087003-Gilchrist1" id="pone.0087003-Gilchrist1" class="link-target"></a>Gilchrist DA, Dos Santos G, Fargo DC, Xie B, Gao Y, et al. (2010) Pausing of RNA polymerase II disrupts DNA-specified nucleosome organization to enable precise gene regulation. Cell 143: 540–551. <ul class="reflinks"><li><a href="#" data-author="Gilchrist" data-cit="GilchristDA%2C%20Dos%20SantosG%2C%20FargoDC%2C%20XieB%2C%20GaoY%2C%20et%20al.%20%282010%29%20Pausing%20of%20RNA%20polymerase%20II%20disrupts%20DNA-specified%20nucleosome%20organization%20to%20enable%20precise%20gene%20regulation.%20Cell%20143%3A%20540%E2%80%93551." data-title="Pausing%20of%20RNA%20polymerase%20II%20disrupts%20DNA-specified%20nucleosome%20organization%20to%20enable%20precise%20gene%20regulation" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Pausing+of+RNA+polymerase+II+disrupts+DNA-specified+nucleosome+organization+to+enable+precise+gene+regulation+Gilchrist+2010" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref36"><span class="order">36.
            </span><a name="pone.0087003-Buratowski1" id="pone.0087003-Buratowski1" class="link-target"></a>Buratowski S (2003) The CTD code. Nat Struct Biol 10: 679–680. <ul class="reflinks"><li><a href="#" data-author="Buratowski" data-cit="BuratowskiS%20%282003%29%20The%20CTD%20code.%20Nat%20Struct%20Biol%2010%3A%20679%E2%80%93680." data-title="The%20CTD%20code" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=The+CTD+code+Buratowski+2003" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref37"><span class="order">37.
            </span><a name="pone.0087003-Buratowski2" id="pone.0087003-Buratowski2" class="link-target"></a>Buratowski S (2009) Progression through the RNA polymerase II CTD cycle. Mol Cell 36: 541–546. <ul class="reflinks"><li><a href="#" data-author="Buratowski" data-cit="BuratowskiS%20%282009%29%20Progression%20through%20the%20RNA%20polymerase%20II%20CTD%20cycle.%20Mol%20Cell%2036%3A%20541%E2%80%93546." data-title="Progression%20through%20the%20RNA%20polymerase%20II%20CTD%20cycle" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Progression+through+the+RNA+polymerase+II+CTD+cycle+Buratowski+2009" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref38"><span class="order">38.
            </span><a name="pone.0087003-Biswas1" id="pone.0087003-Biswas1" class="link-target"></a>Biswas D, Milne TA, Basrur V, Kim J, Elenitoba-Johnson KS, et al. (2011) Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes. Proc Natl Acad Sci U S A 108: 15751–15756. <ul class="reflinks"><li><a href="#" data-author="Biswas" data-cit="BiswasD%2C%20MilneTA%2C%20BasrurV%2C%20KimJ%2C%20Elenitoba-JohnsonKS%2C%20et%20al.%20%282011%29%20Function%20of%20leukemogenic%20mixed%20lineage%20leukemia%201%20%28MLL%29%20fusion%20proteins%20through%20distinct%20partner%20protein%20complexes.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A%20108%3A%2015751%E2%80%9315756." data-title="Function%20of%20leukemogenic%20mixed%20lineage%20leukemia%201%20%28MLL%29%20fusion%20proteins%20through%20distinct%20partner%20protein%20complexes" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Function+of+leukemogenic+mixed+lineage+leukemia+1+%28MLL%29+fusion+proteins+through+distinct+partner+protein+complexes+Biswas+2011" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref39"><span class="order">39.
            </span><a name="pone.0087003-Luo1" id="pone.0087003-Luo1" class="link-target"></a>Luo Z, Lin C, Guest E, Garrett AS, Mohaghegh N, et al. (2012) The super elongation complex family of RNA polymerase II elongation factors: gene target specificity and transcriptional output. Mol Cell Biol 32: 2608–2617. <ul class="reflinks"><li><a href="#" data-author="Luo" data-cit="LuoZ%2C%20LinC%2C%20GuestE%2C%20GarrettAS%2C%20MohagheghN%2C%20et%20al.%20%282012%29%20The%20super%20elongation%20complex%20family%20of%20RNA%20polymerase%20II%20elongation%20factors%3A%20gene%20target%20specificity%20and%20transcriptional%20output.%20Mol%20Cell%20Biol%2032%3A%202608%E2%80%932617." data-title="The%20super%20elongation%20complex%20family%20of%20RNA%20polymerase%20II%20elongation%20factors%3A%20gene%20target%20specificity%20and%20transcriptional%20output" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=The+super+elongation+complex+family+of+RNA+polymerase+II+elongation+factors%3A+gene+target+specificity+and+transcriptional+output+Luo+2012" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref40"><span class="order">40.
            </span><a name="pone.0087003-Luo2" id="pone.0087003-Luo2" class="link-target"></a>Luo Z, Lin C, Shilatifard A (2012) The super elongation complex (SEC) family in transcriptional control. Nat Rev Mol Cell Biol 13: 543–547. <ul class="reflinks"><li><a href="#" data-author="Luo" data-cit="LuoZ%2C%20LinC%2C%20ShilatifardA%20%282012%29%20The%20super%20elongation%20complex%20%28SEC%29%20family%20in%20transcriptional%20control.%20Nat%20Rev%20Mol%20Cell%20Biol%2013%3A%20543%E2%80%93547." data-title="The%20super%20elongation%20complex%20%28SEC%29%20family%20in%20transcriptional%20control" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=The+super+elongation+complex+%28SEC%29+family+in+transcriptional+control+Luo+2012" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref41"><span class="order">41.
            </span><a name="pone.0087003-Takahashi1" id="pone.0087003-Takahashi1" class="link-target"></a>Takahashi H, Parmely TJ, Sato S, Tomomori-Sato C, Banks CA, et al. (2011) Human mediator subunit MED26 functions as a docking site for transcription elongation factors. Cell 146: 92–104. <ul class="reflinks"><li><a href="#" data-author="Takahashi" data-cit="TakahashiH%2C%20ParmelyTJ%2C%20SatoS%2C%20Tomomori-SatoC%2C%20BanksCA%2C%20et%20al.%20%282011%29%20Human%20mediator%20subunit%20MED26%20functions%20as%20a%20docking%20site%20for%20transcription%20elongation%20factors.%20Cell%20146%3A%2092%E2%80%93104." data-title="Human%20mediator%20subunit%20MED26%20functions%20as%20a%20docking%20site%20for%20transcription%20elongation%20factors" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Human+mediator+subunit+MED26+functions+as+a+docking+site+for+transcription+elongation+factors+Takahashi+2011" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref42"><span class="order">42.
            </span><a name="pone.0087003-Hu1" id="pone.0087003-Hu1" class="link-target"></a>Hu X, Malik S, Negroiu CC, Hubbard K, Velalar CN, et al. (2006) A Mediator-responsive form of metazoan RNA polymerase II. Proc Natl Acad Sci U S A 103: 9506–9511. <ul class="reflinks"><li><a href="#" data-author="Hu" data-cit="HuX%2C%20MalikS%2C%20NegroiuCC%2C%20HubbardK%2C%20VelalarCN%2C%20et%20al.%20%282006%29%20A%20Mediator-responsive%20form%20of%20metazoan%20RNA%20polymerase%20II.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A%20103%3A%209506%E2%80%939511." data-title="A%20Mediator-responsive%20form%20of%20metazoan%20RNA%20polymerase%20II" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=A+Mediator-responsive+form+of+metazoan+RNA+polymerase+II+Hu+2006" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref43"><span class="order">43.
            </span><a name="pone.0087003-Wilda1" id="pone.0087003-Wilda1" class="link-target"></a>Wilda M, Busch K, Klose I, Keller T, Woessmann W, et al. (2004) Level of MYC overexpression in pediatric Burkitt’s lymphoma is strongly dependent on genomic breakpoint location within the MYC locus. Genes Chromosomes Cancer 41: 178–182. <ul class="reflinks"><li><a href="#" data-author="Wilda" data-cit="WildaM%2C%20BuschK%2C%20KloseI%2C%20KellerT%2C%20WoessmannW%2C%20et%20al.%20%282004%29%20Level%20of%20MYC%20overexpression%20in%20pediatric%20Burkitt%E2%80%99s%20lymphoma%20is%20strongly%20dependent%20on%20genomic%20breakpoint%20location%20within%20the%20MYC%20locus.%20Genes%20Chromosomes%20Cancer%2041%3A%20178%E2%80%93182." data-title="Level%20of%20MYC%20overexpression%20in%20pediatric%20Burkitt%E2%80%99s%20lymphoma%20is%20strongly%20dependent%20on%20genomic%20breakpoint%20location%20within%20the%20MYC%20locus" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Level+of+MYC+overexpression+in+pediatric+Burkitt%E2%80%99s+lymphoma+is+strongly+dependent+on+genomic+breakpoint+location+within+the+MYC+locus+Wilda+2004" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref44"><span class="order">44.
            </span><a name="pone.0087003-Kellner1" id="pone.0087003-Kellner1" class="link-target"></a>Kellner WA, Van Bortle K, Li L, Ramos E, Takenaka N, et al.. (2013) Distinct isoforms of the Drosophila Brd4 homologue are present at enhancers, promoters and insulator sites. Nucleic Acids Res. <ul class="find-nolinks"></ul></li><li id="ref45"><span class="order">45.
            </span><a name="pone.0087003-Loven1" id="pone.0087003-Loven1" class="link-target"></a>Loven J, Hoke HA, Lin CY, Lau A, Orlando DA, et al. (2013) Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153: 320–334. <ul class="reflinks"><li><a href="#" data-author="Loven" data-cit="LovenJ%2C%20HokeHA%2C%20LinCY%2C%20LauA%2C%20OrlandoDA%2C%20et%20al.%20%282013%29%20Selective%20inhibition%20of%20tumor%20oncogenes%20by%20disruption%20of%20super-enhancers.%20Cell%20153%3A%20320%E2%80%93334." data-title="Selective%20inhibition%20of%20tumor%20oncogenes%20by%20disruption%20of%20super-enhancers" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Selective+inhibition+of+tumor+oncogenes+by+disruption+of+super-enhancers+Loven+2013" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref46"><span class="order">46.
            </span><a name="pone.0087003-Zhang1" id="pone.0087003-Zhang1" class="link-target"></a>Zhang W, Prakash C, Sum C, Gong Y, Li Y, et al. (2012) Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J Biol Chem 287: 43137–43155. <ul class="reflinks"><li><a href="#" data-author="Zhang" data-cit="ZhangW%2C%20PrakashC%2C%20SumC%2C%20GongY%2C%20LiY%2C%20et%20al.%20%282012%29%20Bromodomain-containing%20protein%204%20%28BRD4%29%20regulates%20RNA%20polymerase%20II%20serine%202%20phosphorylation%20in%20human%20CD4%2B%20T%20cells.%20J%20Biol%20Chem%20287%3A%2043137%E2%80%9343155." data-title="Bromodomain-containing%20protein%204%20%28BRD4%29%20regulates%20RNA%20polymerase%20II%20serine%202%20phosphorylation%20in%20human%20CD4%2B%20T%20cells" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Bromodomain-containing+protein+4+%28BRD4%29+regulates+RNA+polymerase+II+serine+2+phosphorylation+in+human+CD4%2B+T+cells+Zhang+2012" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref47"><span class="order">47.
            </span><a name="pone.0087003-Peterlin1" id="pone.0087003-Peterlin1" class="link-target"></a>Peterlin BM, Brogie JE, Price DH (2012) 7SK snRNA: a noncoding RNA that plays a major role in regulating eukaryotic transcription. Wiley Interdiscip Rev RNA 3: 92–103. <ul class="reflinks"><li><a href="#" data-author="Peterlin" data-cit="PeterlinBM%2C%20BrogieJE%2C%20PriceDH%20%282012%29%207SK%20snRNA%3A%20a%20noncoding%20RNA%20that%20plays%20a%20major%20role%20in%20regulating%20eukaryotic%20transcription.%20Wiley%20Interdiscip%20Rev%20RNA%203%3A%2092%E2%80%93103." data-title="7SK%20snRNA%3A%20a%20noncoding%20RNA%20that%20plays%20a%20major%20role%20in%20regulating%20eukaryotic%20transcription" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=7SK+snRNA%3A+a+noncoding+RNA+that+plays+a+major+role+in+regulating+eukaryotic+transcription+Peterlin+2012" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref48"><span class="order">48.
            </span><a name="pone.0087003-Bartholomeeusen1" id="pone.0087003-Bartholomeeusen1" class="link-target"></a>Bartholomeeusen K, Xiang Y, Fujinaga K, Peterlin BM (2012) Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein. J Biol Chem 287: 36609–36616. <ul class="reflinks"><li><a href="#" data-author="Bartholomeeusen" data-cit="BartholomeeusenK%2C%20XiangY%2C%20FujinagaK%2C%20PeterlinBM%20%282012%29%20Bromodomain%20and%20extra-terminal%20%28BET%29%20bromodomain%20inhibition%20activate%20transcription%20via%20transient%20release%20of%20positive%20transcription%20elongation%20factor%20b%20%28P-TEFb%29%20from%207SK%20small%20nuclear%20ribonucleoprotein.%20J%20Biol%20Chem%20287%3A%2036609%E2%80%9336616." data-title="Bromodomain%20and%20extra-terminal%20%28BET%29%20bromodomain%20inhibition%20activate%20transcription%20via%20transient%20release%20of%20positive%20transcription%20elongation%20factor%20b%20%28P-TEFb%29%20from%207SK%20small%20nuclear%20ribonucleoprotein" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Bromodomain+and+extra-terminal+%28BET%29+bromodomain+inhibition+activate+transcription+via+transient+release+of+positive+transcription+elongation+factor+b+%28P-TEFb%29+from+7SK+small+nuclear+ribonucleoprotein+Bartholomeeusen+2012" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref49"><span class="order">49.
            </span><a name="pone.0087003-Levens1" id="pone.0087003-Levens1" class="link-target"></a>Levens D (2010) You Don’t Muck with MYC. Genes Cancer 1: 547–554. <ul class="reflinks"><li><a href="#" data-author="Levens" data-cit="LevensD%20%282010%29%20You%20Don%E2%80%99t%20Muck%20with%20MYC.%20Genes%20Cancer%201%3A%20547%E2%80%93554." data-title="You%20Don%E2%80%99t%20Muck%20with%20MYC" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=You+Don%E2%80%99t+Muck+with+MYC+Levens+2010" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref50"><span class="order">50.
            </span><a name="pone.0087003-Dooley1" id="pone.0087003-Dooley1" class="link-target"></a>Dooley S, Wundrack I, Welter C, Blin N (1994) Constitutive C-myc overexpression and p1/p2 promoter shift in a small-cell lung-cancer cell-line. Int J Oncol 5: 65–68. <ul class="reflinks"><li><a href="#" data-author="Dooley" data-cit="DooleyS%2C%20WundrackI%2C%20WelterC%2C%20BlinN%20%281994%29%20Constitutive%20C-myc%20overexpression%20and%20p1%2Fp2%20promoter%20shift%20in%20a%20small-cell%20lung-cancer%20cell-line.%20Int%20J%20Oncol%205%3A%2065%E2%80%9368." data-title="Constitutive%20C-myc%20overexpression%20and%20p1%2Fp2%20promoter%20shift%20in%20a%20small-cell%20lung-cancer%20cell-line" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Constitutive+C-myc+overexpression+and+p1%2Fp2+promoter+shift+in+a+small-cell+lung-cancer+cell-line+Dooley+1994" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref51"><span class="order">51.
            </span><a name="pone.0087003-Mohan1" id="pone.0087003-Mohan1" class="link-target"></a>Mohan M, Lin C, Guest E, Shilatifard A (2010) Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis. Nat Rev Cancer 10: 721–728. <ul class="reflinks"><li><a href="#" data-author="Mohan" data-cit="MohanM%2C%20LinC%2C%20GuestE%2C%20ShilatifardA%20%282010%29%20Licensed%20to%20elongate%3A%20a%20molecular%20mechanism%20for%20MLL-based%20leukaemogenesis.%20Nat%20Rev%20Cancer%2010%3A%20721%E2%80%93728." data-title="Licensed%20to%20elongate%3A%20a%20molecular%20mechanism%20for%20MLL-based%20leukaemogenesis" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Licensed+to+elongate%3A+a+molecular+mechanism+for+MLL-based+leukaemogenesis+Mohan+2010" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref52"><span class="order">52.
            </span><a name="pone.0087003-Levine1" id="pone.0087003-Levine1" class="link-target"></a>Levine M (2011) Paused RNA polymerase II as a developmental checkpoint. Cell 145: 502–511. <ul class="reflinks"><li><a href="#" data-author="Levine" data-cit="LevineM%20%282011%29%20Paused%20RNA%20polymerase%20II%20as%20a%20developmental%20checkpoint.%20Cell%20145%3A%20502%E2%80%93511." data-title="Paused%20RNA%20polymerase%20II%20as%20a%20developmental%20checkpoint" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Paused+RNA+polymerase+II+as+a+developmental+checkpoint+Levine+2011" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref53"><span class="order">53.
            </span><a name="pone.0087003-Nechaev1" id="pone.0087003-Nechaev1" class="link-target"></a>Nechaev S, Fargo DC, dos Santos G, Liu L, Gao Y, et al. (2010) Global analysis of short RNAs reveals widespread promoter-proximal stalling and arrest of Pol II in Drosophila. Science 327: 335–338. <ul class="reflinks"><li><a href="#" data-author="Nechaev" data-cit="NechaevS%2C%20FargoDC%2C%20dos%20SantosG%2C%20LiuL%2C%20GaoY%2C%20et%20al.%20%282010%29%20Global%20analysis%20of%20short%20RNAs%20reveals%20widespread%20promoter-proximal%20stalling%20and%20arrest%20of%20Pol%20II%20in%20Drosophila.%20Science%20327%3A%20335%E2%80%93338." data-title="Global%20analysis%20of%20short%20RNAs%20reveals%20widespread%20promoter-proximal%20stalling%20and%20arrest%20of%20Pol%20II%20in%20Drosophila" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Global+analysis+of+short+RNAs+reveals+widespread+promoter-proximal+stalling+and+arrest+of+Pol+II+in+Drosophila+Nechaev+2010" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li></ol></div>



          <div class="ref-tooltip">
            <div class="ref_tooltip-content">

            </div>
          </div>

        </div>
      </div>
    </div>

  </section>
  <aside class="article-aside">


<!--[if IE 9]>
<style>
.dload-xml {margin-top: 38px}
</style>
<![endif]-->
<div class="dload-menu">
  <div class="dload-pdf">
    <a href="/plosone/article/file?id=10.1371/journal.pone.0087003&type=printable"
       id="downloadPdf" target="_blank">Download PDF</a>
  </div>
  <div data-js-tooltip-hover="trigger" class="dload-hover">&nbsp;
    <ul class="dload-xml" data-js-tooltip-hover="target">
      <li><a href="/plosone/article/citation?id=10.1371/journal.pone.0087003"
             id="downloadCitation">Citation</a></li>
      <li><a href="/plosone/article/file?id=10.1371/journal.pone.0087003&type=manuscript"
             id="downloadXml">XML</a>
      </li>
    </ul>

  </div>
</div>

<div class="aside-container">

<div class="print-article" id="printArticle" data-js-tooltip-hover="trigger">

  Print
  <ul class="print-options" data-js-tooltip-hover="target">
    <li><a href="#" onclick="window.print(); return false;" class="preventDefault" id="printBrowser">Print article</a></li>

<li><a href="http://surveys.plos.org/s3/reprints">Reprints</a></li>

  </ul>
</div>

<div class="share-article" id="shareArticle" data-js-tooltip-hover="trigger">
  Share
  <ul data-js-tooltip-hover="target" class="share-options" id="share-options">

<li><a href="https://www.reddit.com/submit?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0087003" id="shareReddit" target="_blank" title="Submit to Reddit"><img src="/resource/img/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

<li><a href="https://www.facebook.com/share.php?u=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0087003&t=Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells" id="shareFacebook" target="_blank" title="Share on Facebook"><img src="/resource/img/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>


<li><a href="https://www.linkedin.com/shareArticle?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0087003&title=Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells&summary=Checkout this article I found at PLOS"  id="shareLinkedIn" target="_blank" title="Add to LinkedIn"><img src="/resource/img/icon.linkedin.16.png" width="16" height="16" alt="LinkedIn">LinkedIn</a></li>

<li><a href="https://www.mendeley.com/import/?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0087003"  id="shareMendeley" target="_blank" title="Add to Mendeley"><img src="/resource/img/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

  <li><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0087003&text=%23PLOSONE%3A%20Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells" target="_blank" title="share on Twitter" id="twitter-share-link"><img src="/resource/img/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

<li><a href="mailto:?subject=Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells&body=I%20thought%20you%20would%20find%20this%20article%20interesting.%20From%20PLOS ONE:%20https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0087003"  id="shareEmail" rel="noreferrer" aria-label="Email"><img src="/resource/img/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
<script src="/resource/js/components/tweet140.js" type="text/javascript"></script>
  </ul>
</div></div>


     <!-- Crossmark 2.0 widget -->
    <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script>
    <a aria-label="Check for updates via CrossMark" data-target="crossmark">
      <img alt="Check for updates via CrossMark" width="150" src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_BW_horizontal.svg">
    </a>
    <!-- End Crossmark 2.0 widget -->


  <div class="related-articles-container">
    <h3>
Related PLOS Articles
</h3>
    <ul class="related-articles">
        <li>
          <b>
            has CORRECTION
            
          </b>
        </li>
            <li>
<?xml version="1.0" encoding="UTF-8"?>Correction: Regulation of <i>MYC</i> Expression and Differential JQ1 Sensitivity in Cancer Cells              <ul class="related-article-links">
                <li class="related-article-link-page">
                  <a href="/plosone/article?id=10.1371/journal.pone.0126328">View Page</a>
                </li>
                <!--  Annotations and issue images do not have printables. They can be filtered by doi. -->
                  <li class="related-article-link-download">
                    <a href="/plosone/article/file?type=printable&id=10.1371/journal.pone.0126328"
                       target="_blank" title="PDF opens in new window">PDF</a>
                  </li>
              </ul>
            </li>
    </ul>
  </div>


<script type="text/javascript">
  var articleDoi = "10.1371/journal.pone.0087003";
  $.ajax({
    url: "https://frontpage.plos.org/wp-json/collections-api/contains",
    data: {id: articleDoi},
    context: document.body,
    timeout: 10000,
    dataType: "json",
    success: function (result, textStatus, xOptions) {
      if (result.response == "success" && result.data.collections.length > 0) {
        var articleCollectionsTemplate = _.template($('#articleCollectionsTemplate').html());
        var articleCollectionsHTML = articleCollectionsTemplate(result.data)
        $('.collections-aside-container').append(articleCollectionsHTML);
      }
    }
  });
</script>

<script type="text/template" id="articleCollectionsTemplate">
  <h3>Included in the Following <% if (collections.length == 1) { %>Collection<% } else { %>Collections<% } %></h3>
  <ul id="collectionList">
  <% _.each(collections, function (collection) { %>
    <li>
      <a href="<%= collection.permalink %>"><%= collection.title %></a>
    </li>
  <% }); %>
  </ul>
</script>

<div class="aside-container collections-aside-container">
</div>


<div class="skyscraper-container">
  <div class="title">Advertisement</div>
<!-- DoubleClick Ad Zone -->
  <div class='advertisement' id='div-gpt-ad-1458247671871-1' style='width:160px; height:600px;'>
    <script type='text/javascript'>
      googletag.cmd.push(function() { googletag.display('div-gpt-ad-1458247671871-1'); });
    </script>
  </div>
</div>




<div class="subject-areas-container">
  <h3>Subject Areas <div id="subjInfo">?</div>
    <div id="subjInfoText">
      <p>For more information about PLOS Subject Areas, click
        <a href="https://github.com/PLOS/plos-thesaurus/blob/master/README.md" target="_blank" title="Link opens in new window">here</a>.</p>
      <span class="inline-intro">We want your feedback.</span> Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!


    </div>
  </h3>
  <ul id="subjectList">
      <li>
              <a class="taxo-term" title="Search for articles about Raji cells"
                 href="/plosone/search?filterSubjects=Raji+cells&filterJournals=PLoSONE&q=">Raji cells</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="Raji cells"><p class="taxo-explain">Is the Subject Area <strong>"Raji cells"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
      <li>
              <a class="taxo-term" title="Search for articles about Transcriptional control"
                 href="/plosone/search?filterSubjects=Transcriptional+control&filterJournals=PLoSONE&q=">Transcriptional control</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="Transcriptional control"><p class="taxo-explain">Is the Subject Area <strong>"Transcriptional control"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
      <li>
              <a class="taxo-term" title="Search for articles about DNA transcription"
                 href="/plosone/search?filterSubjects=DNA+transcription&filterJournals=PLoSONE&q=">DNA transcription</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="DNA transcription"><p class="taxo-explain">Is the Subject Area <strong>"DNA transcription"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
      <li>
              <a class="taxo-term" title="Search for articles about Cancers and neoplasms"
                 href="/plosone/search?filterSubjects=Cancers+and+neoplasms&filterJournals=PLoSONE&q=">Cancers and neoplasms</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="Cancers and neoplasms"><p class="taxo-explain">Is the Subject Area <strong>"Cancers and neoplasms"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
      <li>
              <a class="taxo-term" title="Search for articles about Lymphoma"
                 href="/plosone/search?filterSubjects=Lymphoma&filterJournals=PLoSONE&q=">Lymphoma</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="Lymphoma"><p class="taxo-explain">Is the Subject Area <strong>"Lymphoma"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
      <li>
              <a class="taxo-term" title="Search for articles about Transcription factors"
                 href="/plosone/search?filterSubjects=Transcription+factors&filterJournals=PLoSONE&q=">Transcription factors</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="Transcription factors"><p class="taxo-explain">Is the Subject Area <strong>"Transcription factors"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
      <li>
              <a class="taxo-term" title="Search for articles about Chromatin immunoprecipitation"
                 href="/plosone/search?filterSubjects=Chromatin+immunoprecipitation&filterJournals=PLoSONE&q=">Chromatin immunoprecipitation</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="Chromatin immunoprecipitation"><p class="taxo-explain">Is the Subject Area <strong>"Chromatin immunoprecipitation"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
      <li>
              <a class="taxo-term" title="Search for articles about Elongation factors"
                 href="/plosone/search?filterSubjects=Elongation+factors&filterJournals=PLoSONE&q=">Elongation factors</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="Elongation factors"><p class="taxo-explain">Is the Subject Area <strong>"Elongation factors"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
  </ul>
</div>
<div id="subjectErrors"></div>
  </aside>
</div>




</main>
<footer id="pageftr">
  <div class="row">
    <div class="block x-small">

<ul class="nav nav-secondary">
    <li class="ftr-header"><a href="https://plos.org/publications/journals/">Publications</a></li>
    <li><a href="/plosbiology/" id="ftr-bio">PLOS Biology</a></li>
    <li><a href="/plosmedicine/" id="ftr-med">PLOS Medicine</a></li>
    <li><a href="/ploscompbiol/" id="ftr-compbio">PLOS Computational Biology</a></li>
    <li><a href="/plosgenetics/" id="ftr-gen">PLOS Genetics</a></li>
    <li><a href="/plospathogens/" id="ftr-path">PLOS Pathogens</a></li>
    <li><a href="/plosone/" id="ftr-one">PLOS ONE</a></li>
    <li><a href="/plosntds/" id="ftr-ntds">PLOS Neglected Tropical Diseases</a></li>
  </ul>
    </div>
    <div class="block x-small">

<ul class="nav nav-secondary">
    <li class="ftr-header">&nbsp;</li>
    <li><a href="/climate/" id="ftr-climate">PLOS Climate</a></li>
    <li><a href="/digitalhealth/" id="ftr-digitalhealth">PLOS Digital Health</a></li>
    <li><a href="/globalpublichealth/" id="ftr-globalpublichealth">PLOS Global Public Health</a></li>
    <li><a href="/sustainabilitytransformation/" id="ftr-sustainabilitytransformation">PLOS Sustainability and Transformation</a></li>
    <li><a href="/water/" id="ftr-water">PLOS Water</a></li>
  </ul>
    </div>
    <div class="block xx-small">	


<ul class="nav nav-tertiary">
  <li>
    <a href="https://plos.org" id="ftr-home">Home</a>
  </li>
  <li>
    <a href="https://blogs.plos.org" id="ftr-blog">Blogs</a>
  </li>
  <li>
    <a href="https://collections.plos.org/" id="ftr-collections">Collections</a>
  </li>
  <li>
    <a href="mailto:webmaster@plos.org" id="ftr-feedback">Give feedback</a>
  </li>
  <li>
    <a href="/plosone/lockss-manifest" id="ftr-lockss">LOCKSS</a>
  </li>
</ul>
    </div>
    <div class="block xx-small">

<ul class="nav nav-primary">
  <li><a href="https://plos.org/privacy-policy" id="ftr-privacy">Privacy Policy</a></li>
  <li><a href="https://plos.org/terms-of-use" id="ftr-terms">Terms of Use</a></li>
  <li><a href="https://plos.org/advertise/" id="ftr-advertise">Advertise</a></li>
  <li><a href="https://plos.org/media-inquiries" id="ftr-media">Media Inquiries</a></li>
  <li><a href="https://plos.org/contact" id="ftr-contact">Contact</a></li>
</ul>
    </div>
  </div>
  <div class="row">
    <p>

<img src="/resource/img/logo-plos-footer.png" alt="PLOS" class="logo-footer"/>


<span class="footer-non-profit-statement">PLOS is a nonprofit 501(c)(3) corporation, #C2354500, based in San Francisco, California, US</span>    </p>
    <div class="block">

&nbsp;
<!--
  Webapp build:  3.7.29-SNAPSHOT at 20220302030511 by root, commit: addc5e2
  Service build: 2.6.0-SNAPSHOT at 20220222171921 by root, commit: 20f030d
  -->
    </div>
  </div>
 
<script src="/resource/js/global.js" type="text/javascript"></script>
</footer>




<script type="text/javascript">
  var ArticleData = {
    doi: '10.1371/journal.pone.0087003',
    title: '<article-title xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:xlink=\"http://www.w3.org/1999/xlink\">Regulation of <italic>MYC<\/italic> Expression and Differential JQ1 Sensitivity in Cancer Cells<\/article-title>',
    date: 'Jan 23, 2014'
  };
</script>
<script src="/resource/js/components/show_onscroll.js" type="text/javascript"></script>
<script src="/resource/js/vendor/spin.js" type="text/javascript"></script>
<script src="/resource/js/pages/article.js" type="text/javascript"></script>
<script src="/resource/js/pages/article_sidebar.js" type="text/javascript"></script>
<script src="/resource/js/pages/article_references.js" type="text/javascript"></script>
<script src="/resource/js/vendor/foundation/foundation.dropdown.js" type="text/javascript"></script>
  <script src="/resource/js/components/table_open.js" type="text/javascript"></script>

        <script src="/resource/js/components/figshare.js" type="text/javascript"></script>
  <script src="/resource/js/vendor/jquery.panzoom.min.js" type="text/javascript"></script>
  <script src="/resource/js/vendor/jquery.mousewheel.js" type="text/javascript"></script>

  <script src="/resource/js/components/lightbox.js" type="text/javascript"></script>

  <script src="/resource/js/pages/article_body.js" type="text/javascript"></script>


<!-- This file should be loaded before the renderJs, to avoid conflicts with the FigShare, that implements the MathJax also. -->

<!--  mathjax configuration options  -->
<!-- more can be found at http://docs.mathjax.org/en/latest/ -->
<script type="text/x-mathjax-config">
MathJax.Hub.Config({
  "HTML-CSS": {
    scale: 100,
    availableFonts: ["STIX","TeX"],
    preferredFont: "STIX",
    webFont: "STIX-Web",
    linebreaks: { automatic: false }
  },
  jax: ["input/MathML", "output/HTML-CSS"]
});
</script>

<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=MML_HTMLorMML"></script>

<div class="reveal-modal-bg"></div>
</body>
</html>
